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 Abstract 
 
 
Calcium imaging is one of the standard methods used in physiology and cell 
biology to report activity of various cell-types, with a special class of calcium 
sensors called the Genetically-Encoded Calcium Indicators (GECIs) being 
developed during the last ten years. 
Our lab created a GECI that makes use of Fluorescence Resonance Energy 
Transfer (FRET) using spectral variants of GFP, namely CFP and YFP. Both 
fluorescent proteins enwrap the chicken skeletal troponin C (csTnC) that is 
able to bind calcium and therefore modulates FRET which is used as 
fluorescence readout. The first generation of troponin C-based GECIs, TN-
L15, reported calcium changes in cell culture and transgenic animals but 
showed insufficient signal strength to small calcium fluctuations and poor 
kinetics. The aim of this research was to enhance the response properties of 
TN-L15 with respect to signal strength and kinetics. By using a circularly 
permuted acceptor variant, the introduction of point mutations inside the 
csTnC backbone and a ‘doubling’ of the mutated C-terminal domain of csTnC, 
new troponin C-based GECIs could be developed. Point mutating the calcium 
binding loops III and IV of the csTnC backbone in TN-L15 led to an indicator 
with fast kinetics, named TN-XL. Additionally, a profound rearrangement of 
the calcium binding domain, the doubling of the C-terminal part of csTnC, 
yields another version of troponin C-based GECIs. This indicator, named TN-
XXL, showed a 2.4 fold increase in signal strength according to the calcium 
regime up to 1.35 μM when compared to TN-L15. Transgenic expression of 
TN-XL and TN-XXL at the Drosophila larval neuromuscular junction (NMJ) 
confirmed the improvement of these indicators when comparing the response 
properties of troponin C-based GECIs in vivo. Furthermore by using TN-XXL it 
was possible to record single action potentials in organotypic hippocampal 
slices using patch clamp techniques. Finally, by viral expression of TN-XXL in 
the primary visual cortex of mice, the indicator was able to detect sensory 
evoked calcium transients in vivo. 

 Introduction 
 
 
Fluorescence imaging has become one of the most powerful tools in biology 
during the last few decades, in part due to the event of fluorescence occurring 
at a time scale of about 10-9 s, making it suitable for detecting various 
biological and biochemical processes. Among these, shuttling of proteins 
between distinct cellular organelles or changes in intracellular messengers 
such as calcium can be detected by using fluorescence techniques. 
Fluorescence microscopy is a very sensitive method since it enables the 
detection of low levels of light that is emitted by a fluorescent probe. The high 
sensitivity of fluorescence microscopy is provided by the separation of the 
fluorescent probe and an (ideally) non-fluorescent background which does not 
contribute to emitted photons that are detected. 
Fluorescence microscopy techniques have undergone many improvements 
over the last few years. On the one hand fluorescence microscopy has 
improved in terms of single photon microscopy such as STED (1) or PALM (2) 
microscopy. These two techniques allow for nanoscale fluorescence 
microscopy down to 20 nm lateral resolution (2, 3) that, in turn, shows that the 
diffraction limit as described by E. Abbe in 1873 is not longer valid. On the 
other hand multiphoton microscopy like 2P-microscopy (2-photon) exploits 
longer wavelength excitation light and therefore achieves larger penetration 
depths into biological tissue by using a pulsed laser to excite a given 
chromophore ‘in two steps’ (4). This technique highlights a milestone for 
biological imaging since it expanded the access to deeper structures. In that 
line the use of fiber optics has led to an even higher penetration of biological 
systems in terms of implanting a fiber coupled lens directly to a given structure 
like the hippocampus (5). 
Beside these technical improvements innovations in the field of fluorescent 
dyes (small synthetic dyes, fluorescent proteins, small synthetic indicators or 
genetically-encoded sensors of biological processes) has led to a new era of 
visualizing biological processes. Fluorescent tagging of proteins can be 
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achieved by simply expanding the protein’s DNA of interest with the coding 
sequence of a given fluorescent protein. Additionally fluorescent highlighting 
can be attained with small biarsenical synthetic dyes attached to the protein 
via a tetracysteine motif (6, 7). Up to now fluorescent compounds, synthetic or 
genetically-encoded, have been developed into functional biosensors to 
monitor a variety of biological processes. 
 
 
2.1. Fluorescence 
 
Fluorescence can be grouped together with phosphorescence to form the 
phenomenon called luminescence. Hereby we will define an event exploiting 
the conversion of energy evoked by an appropriate molecule that absorbs a 
photon of a given energy level. The energy of this photon elicits a transition of 
an electron in the ground state to an excited singlet state (absorption) 
whereby the electron in the excited orbital is of opposite spin to the electron in 
the ground state orbital. From this excited state the electron returns to its 
ground state within a short period of time, with a typical fluorescence lifetime 
(τ) of 1 - 10 x 10-9 s. During this time between excitation and the return to the 
ground state a photon is released (emission) (Figure 1). Absorption usually 
takes place at the lowest vibrational level (v = 0) of the lowest energy state 
(S0), thus, after light absorption an electron is shifted to higher vibrational 
levels (e.g. v = 1, 2) in higher energy states (e.g. S1, S2). Return from higher 
vibrational levels to the lowest vibrational level in the excited energy state (S1) 
is called ‘Internal Conversion’ and occurs within 10-12 s. This is much faster 
than the fluorescence lifetime and the return of the excited electron to the 
lowest vibrational level in S1 is completed before emission and results in a 
thermally equilibrated state. From this state the electron drops back to the 
ground state where it usually occupies a higher vibrational level before it 
returns to the lowest vibrational level in S0 (within 10-12 s, in terms of heat). As 
a result of the energy difference of the electron that is excited by an absorbed 
photon (hνA) compared to the electron that cause emission of a photon (hνE) 
5 
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the required wavelength of the absorbed photon is smaller than that of the 
emitted photon. This red-shift between excitation and emission is called 
‘Stokes’ Shift’. Since excitation occurs on a very fast time scale (10-15 s) the 
distance of the nuclei will not change during excitation, an observation called 
the ‘Franck-Condon Principle’. Distinct transitions of an electron to vibrational 
levels in the excited electronic state are occurring proportionately to the 
overlap of their vibrational wave functions. After relaxation to the lowest 
vibrational level of S1 transitions to distinct vibrational levels in S0 (e.g. S1, v = 
0 to S0, v = 2) occur at the same frequency as transitions after excitation to 
distinct vibrational levels in S1 (e.g. S0, v = 0 to S1, v = 2). Therefore emission 
spectra are red-shifted to the corresponding excitation spectra and often 
display mirror symmetry. 
An alternative way for the excited state electron to decay is provided by an 
‘Intersystem Crossing’. This action comes along with a spin conversion and 
ends in the first triplet state (T1) (Figure 1). Transition from T1 to S0 is 
forbidden due to the same spin orientation of the electrons in both states 
resulting in a longer lifetime of the triplet electron (10-2 s - minutes) compared 
to the lifetime of the singlet excited state. This phenomenon is called 
phosphorescence.  
 
 
Figure 1: Jablonski diagram 
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One important characteristic of a fluorophore is its quantum yield (Q) that can 
be defined as the ratio between emitted and absorbed photons. It can be 
determined by the rates of emissive (relaxation of the excited state electron to 
the ground state by emission of a photon) and non-emissive (relaxation of the 
excited state electron to the ground state by non-emissive processes, e.g. 
quenching) decay properties: 
 
nek
Q +Γ
Γ=  
 
Q  = quantum yield 
Γ  = rate of emissive decay [s-1] 
kne  = rate of non-emissive decay [s-1] 
 
If the rate of non-emissive decay is much smaller than the emissive decay of 
the excited electron this equation reaches approximately 1, that in turn 
resembles an almost 100 % conversion of all absorbed photons to emitted 
photons. A number of different events can cause a reduction of the quantum 
yield and hence the intensity of fluorescence and such processes are referred 
to the ‘Quenching Phenomenon’. Collisional Quenching (deactivation of the 
excited state through contact with other molecules), Fluorescence Resonance 
Energy Transfer (FRET, non-radiative transfer of the excited state energy to 
an acceptor molecule) or Static Quenching (formation of non-fluorescent 
complexes with other molecules) are the most common mechanisms to 
reduce the quantum yield of a fluorophore. In addition, another important 
factor that should be considered when describing a fluorescent probe is its 
molar extinction coefficient (ε). This defines the amount of absorbed photons 
of a given substance at a defined wavelength measured in an absorption 
photometer (at a concentration of 1 mol/l with a pathlength of 1 cm). 
Combined, both factors together determine the overall brightness of a 
fluorophore. 
Reduction of the fluorescence of a given species can also be due to a 
particular mechanism called Photoisomerization. As describe for the wild type 
7 
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Green Fluorescent Protein (GFP), which possesses two absorption peaks 
(395 nm and 475 nm), strong illumination of the 395 nm excitation peak 
causes the decline of this particular excitation peak and shifts the absorption 
towards the second peak at 475 nm because of the isomerization to the 
anionic form of the chromophore and hence a loss of fluorescence (8). For a 
detailed description of the wild type GFP the reader is referred to the 
‘Fluorescent Proteins’ section (2.3.). 
Besides quenching and photoisomerization, one additional phenomenon can 
be observed in fluorescence spectroscopy namely Photobleaching. Usually 
the excitation/emission cycle of a fluorophore occurs over ten thousand times 
before photobleaching takes place (9). As mentioned above the excited state 
of a fluorophore can come in two forms: the short lived singlet state and the 
long-lived triplet state. It is thought that the triplet state interacts with other 
molecules (also in the triplet state) especially molecular oxygen. Transfer of 
energy from the fluorophore to oxygen will cause activation of the latter to its 
singlet excited state that is capable of proceeding chemical reactions, e.g. 
with the chromophore itself. This can lead to an irreversible destruction of the 
fluorophore and hence loss of fluorescence (9). 
 
 
2.2. Fluorescence Resonance Energy Transfer (FRET) 
 
The first description of Fluorescence Resonance Energy Transfer (FRET) was 
provided by Theodor Förster in the middle of the 20th century (hence FRET 
can also be referred to as Förster Resonance Energy Transfer) and can 
largely be regarded as a special case of quenching. In this case an excited 
state fluorophore (donor) transfers its energy to an acceptor molecule that in 
turn reaches its excited state without emission of a photon from the donor. For 
FRET to occur the spectral properties of donor and acceptor have to fulfill 
some important criteria that will be described in this part.  
FRET-efficiency strongly depends on the distance of two chromophores and 
can be described as follows: 
8 
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66
0
6
0
rR
REFRET +=  
 
EFRET = FRET-efficiency 
R0 = Förster radius [nm] 
r = distance [nm] 
 
The constant R0 (also named Förster radius) defines the distance of a given 
FRET pair at which the efficiency of energy transfer reaches half-maximum. It 
can be calculated according to the equation: 
 
( )[ ]λκ JQnR D422560 10*79.8 −−=  
 
R06 =  Förster distance [cm6] 
n =  refractive index of the medium 
QD = quantum yield of donor in the absence of acceptor 
J(λ) = overlap integral [M-1 cm3] 
 
Note: The factor 8.79 x 10-25 is calculated from physical constants among 
them the Avogadro’s number that occurs in the denominator and therefore 
provides the dimension [mol]. 
 
 
There are two important factors that define the Förster distance and hence the 
FRET-efficiency, namely the overlap integral J(λ) of donor emission and 
acceptor excitation and the orientation factor κ2 that describes the orientation 
of the transition dipoles of the two fluorophores. The overlap integral can be 
described as follows: 
 
∫
∞
=
0
4)()()( λλλελλ dFJ AD  
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J(λ) = overlap integral [M-1 cm3] 
FD(λ) = normalized fluorescence intensity of the donor  
εA(λ) =  extinction coefficient of the acceptor at λ [M-1 cm-1] 
λ = wavelength [cm] 
 
The second dependence of FRET-efficiency is defined by the orientation of 
the transition dipoles that abstract the fluorophores (emission transition dipole 
of donor and absorption transition dipole of acceptor). This relation is 
expressed by the orientation factor κ2 that can be calculated from: 
 
( )22 coscos3cos ADT θθθκ −=  
 
θT = angle between transition dipole of emission of donor and 
transition dipole of absorption of acceptor 
θD/A = angle between the depicted transition dipole and the vector 
joining donor and acceptor  
 
Figure 2 represents a schematic diagram of the vectors and angles that define 
the orientation factor κ2. It is interesting to note that κ2 can have values from 0 
to 4. If the transition dipoles are oriented perpendicular to each other κ2 
becomes 0 and subsequently FRET does not occur. 
 
 
Figure 2: Dependency of κ2 on the directions of the transition dipoles. 
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For practical use one has to mention that distance is the primary factor that 
varies FRET-efficiency. For small fluorescent dyes (particularly in solution and 
freely diffused but also attached via a freely rotating covalent bond) the 
orientation factor can be defined as constant 2/3. Additionally the overlapping 
integral is fixed for a given FRET pair and consequently this is the reason why 
FRET was primarily used as a ‘molecular ruler’ to measure distances. One 
exception to this rule is the intramolecular fusion of two fluorescent proteins 
that are suitable for FRET. In this case the orientation is relatively rigid 
according to the protein structure and allows tuning of FRET-efficiency by 
altering the orientation of donor and acceptor transition dipoles. 
 
 
2.3. Fluorescent Proteins 
 
Beside the well established small fluorescent synthetic compounds like 
fluorescein a number of Fluorescent Proteins (FPs) have emerged during the 
last few decades. In this context the discovery of the Green Fluorescent 
Protein (GFP) set a milestone for biological imaging. First described by 
Shimomura and colleagues in 1962 (10) it took approximately 40 years until 
the cDNA was cloned and GFP could be used as a molecular marker in cell 
biology (11, 12). GFP variants were discovered in two different organisms with 
the most commonly used being GFP (which acted as template for 
mutagenesis that yielded the famous EGFP) that was extracted from the 
jellyfish Aequoria victoria (Victoria, British Columbia, Canada) (13). GFP also 
occurs in the sea pansy Renilla reniformis (Georgia, USA) (14). Interestingly 
GFP was discovered as a co-factor that transduces the blue emission of 
aequorin into a greenish light. The mechanism that is utilized refers to RET 
(Resonance Energy Transfer), an energy transfer from the bioluminescent 
aequorin to GFP. Solving the crystal structure revealed that GFP consist of 11 
β-sheets building up a so called β-barrel (or β-can) (Figure 3A).  
This cage-like structure covers a central α-helix at which the matured 
chromophore is tethered (15, 16). The fluorophore of GFP is built from three 
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subsequent amino acid residues namely serine65 (S65), tyrosine66 (Y66) and 
glycine67 (G67). The generation of the fluorescent part, a so called 4-(p-
hydroxybenzylidene)imidazolidin-5-one, is carried out in an autocatalytic 
manner without any external co-factors except of molecular oxygen (8) (Figure 
3B) and allows easy labeling of cells by delivering the DNA that encodes GFP. 
An interesting phenomenon of wild type GFP is its complex spectral 
characteristic. 
 
 
Figure 3: Three dimensional structure of GFP (pdb entry 1Q4A) and the mechanism of 
chromophore formation. 
Picture in (A) was redrawn using DeepView/SwissPdbViewer 3.7. Picture in B is taken from (8). 
 
The fluorescence excitation spectrum contains two peaks (395 nm and 475 
nm) that give rise to almost identical emission peaks at 508 nm and 503 nm 
respectively. The two distinct excitation maxima correspond to two different 
populations of the chromophore. The deprotonated or anionic (phenolate) 
form of the fluorophore (R-) gives rise to the 475 nm peak whereas the 395 
nm peak comes from the protonated form (RH) (8). The excited state of the 
neutral form is thought to be much more acidic. An Excited State Proton 
Transfer (ESPT) occurs giving rise to a deprotonation and therefore a highly 
similar emission spectrum with regard to direct excitation of the deprotonated 
fluorophore (8). Both deprotonated states are not equal i.e. there exist two 
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different stabilized forms. An intermediate I-state formed by excitation and 
subsequent deprotonation (ESPT) of RH and an equilibrated B-state that is 
due to excitation of R-. This results in the slightly variation in emission peaks 
formed by wild type GFP (17) and represents the photophysical basis for 
direct stabilization of the two states that has been achieved by mutating wild 
type GFP to EGFP and the Sapphire variant. EGFP exploits the S65T 
mutation that is known to stabilize the anionic form of the fluorophore and 
hence a single absorption peak at 489 nm (18). On the other hand a sole 
excitation peak at 399 nm is achieved in the Sapphire variant of GFP due to 
the mutation T203I (19). 
Since chromophore formation is realized by the three adjacent amino acids 
wavelength alteration can be obtained by replacing aromatic residues. For 
example the variants CFP (Cyan Fluorescent Protein, indole chromophore, 
Y66W) and BFP (Blue Fluorescent Protein, imidazole chromophore, Y66H) 
emerged by changing a single amino acid residue inside the chromophore 
forming positions (19). In addition of changing an aromatic side one can 
achieve a red shift by a so-called π-stack. A structurally nearby amino acid 
residue (T203Y) gives rise to a stack of two independent π-systems that yield 
the group of YFPs (Yellow Fluorescent Proteins) (8). YFP is sensitive to 
environmental factors like fluctuations in pH or halide concentration (20, 21) 
that can be exploited to record pH or halide changes in cells (22, 23). 
Nevertheless for a biosensor that depends on FRET one would like to have a 
stable variant of YFP that acts as an acceptor. For this reason mutagenesis 
was applied to the YFP that yielded two pH and halide stable variants refering 
to as Citrine and Venus (24-26), both of which are successfully used in FRET-
based biosensors. 
A plethora of different FPs were discovered and subcloned from different 
species during the last years. Particular attention was paid to the discovery of 
red shifted FPs in order to enhance the color spectrum. This has the 
advantage of e.g. multicolor labeling. Most famous among these proteins is 
DsRed from Discosoma striata, the first Red Fluorescent Protein (RFP) that 
has been discovered (27). This obligate tetramer was finally engineered to the 
monomer mRFP1 (λPeakExc 584 nm/λPeakEm 607 nm) (28) which marked the 
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basis of a more recent broadening of the FP spectrum. Using the technique of 
somatic hypermutation and random mutagenesis the group of Roger Tsien 
could develop the so called mFruits, fluorescent proteins that cover almost the 
entire visible spectrum (29, 30). 
 
 
2.4. Genetically-Encoded Calcium Indicators (GECIs) 
 
To decipher various system or cell biological events one has to possess the 
capability of detecting these. In neurobiology the standard method to obtain 
information about the activity of distinct neurons is electrophysiology; with the 
use of patch clamping or sharp electrode techniques allowing the time course 
of electrical activity from individual nerve cells to be recorded.  
Although changes in the membrane potential are directly linked to activity of 
neurons, they are hard to detect by optical means. Optical imaging of the 
membrane potential would have the advantage to record the activity of a huge 
number of neurons simultaneously. This in turn would make this technique 
superior to electrophysiology where only a single or a few cells can be 
recorded at the same time. There exist a number of optic voltage sensors 
mainly synthetic ones (31-34) but none of these sensors provided the basis 
for practical usage in neuroscience so far.  
To circumvent these problems an alternative approach has emerged in the 
last few years. In order to detect activity of neurons directly one can use the 
visualization of calcium transients that correspond to electrical activity. Also 
here the first sensors were based on small organic compounds like EGTA. A 
couple of different synthetic calcium sensors were developed among these 
e.g. OGB-1 (35), the stil-, fura-, indo-family (36) and the rhod- and fluo-family 
(37). 
Synthetic dyes can be applied to a cell by loading with electrodes. In this case 
only one or a small subset of cells will be labeled (usually when more than 
one electrode is used). Alternatively the so-called AM-derivatives 
(acetoxymethylesters) of small molecule sensors can be used to incorporate 
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the indicator of choice in more than one particular cell. AM-derivatives of 
synthetic indicators can pass biological membranes and undergo cleavage 
inside the cytosol by intracellular esterases. The cleaved form of the AM-ester 
is eventually trapped inside the cell. A novel approach to yield in vivo labeling 
for a population of cells - the so called bulk loading technique - was recently 
developed by Stosiek and colleagues (38). 
A different method to increase the amount of neurons from which signals can 
be recorded is genetic labeling. Therefore a genetically-encoded calcium 
sensor (GECI) can be used that additionally allows, by using an appropriate 
promoter system, labeling of a distinct population or sub-population of 
neurons. A GECI is a calcium biosensor with a fluorescent and a calcium 
binding domain that are entirely genetically-encoded. Another important 
advantage of using GECIs is that they can be targeted to defined 
compartments inside a cell. In that respect the labeling of Golgi (24), 
mitochondria (39), nucleus (40) or the plasma membrane (41) has been 
achieved. 
Protein-based calcium chelation is the initial step in the cascade leading to 
manipulation of a biosensor’s fluorescence output. The nature of the 
appropriate binding sites determines the properties of a biosensor and the 
design options for sensor construction. It is therefore worthwhile to have a 
closer look at the molecular constitution and functional characteristics of these 
motifs. Apart from some unconventional calcium binding sites (for example in 
calpains (42)) there are two prominent types of intracellular calcium binding 
motifs that are able to chelate calcium in the physiologically relevant range, 
the C2 domain and the EF-hand.  
The C2 domain is found in a huge variety of different proteins e.g. 
phospholipase A2 (PLA2), phospholipase C (PLC), protein kinase C (PKC) or 
synaptotagmin (43). A feature of many C2 domains is that they bind calcium 
and phospholipids although there are variants that have evolved to bind other 
targets. PKC was the first protein where the C2 domain was found. It consists 
of ~130 amino acid residues and the structure reveals a scaffold consisting of 
eight β-sheets. On top of this scaffold three loops are attached that promote 
calcium and phospholipid binding. It is interesting to note that the coordination 
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sphere is provided by residues that are not neighbored in the linear sequence 
and that the phospholipid can act as a ligand for calcium binding as it has 
been shown for the PKC-C2 domain (44). Calcium can be bound in the 
absence of a phospholipid although presence of the latter increases the 
affinity for this particular ion. For example, the Kd value for calcium of the C2A 
domain of synaptotagmin I is >1 mM but is decreased about 1000-fold in the 
presence of phospholipids (43). C2 domains apparently do not display a 
significant structural rearrangement of the protein backbone upon calcium 
binding as shown for the C2A domain of synaptotagmin I (45). Due to the 
interrelationship between phospholipid and calcium binding, the large domain 
size with chelating residues distributed far apart and the possible binding to 
other targets C2 domains appear not a first choice for indicator construction. 
Thus a more suitable candidate for GECIs is the well-known calcium binding 
protein domain called EF-hand. It was first described in parvalbumin (46) and 
represents a helix-loop-helix motif of ~30 amino acids that is capable of 
coordinating one calcium (or magnesium) ion. Usually EF-hands occur as 
pairs in proteins so that most EF-hand containing polypeptides have 2, 4, 6 or 
more EF-hand domains. The most important part of the domain is the loop 
region that gives rise to the coordination space through predominantly 
negatively charged amino acid residues. Most EF-hand containing proteins 
possess the so called canonical EF-hand. This version of the domain exhibits 
a 12 residue calcium binding loop consisting of 9 residues in the loop region 
and 3 residues in the exiting helical part of the EF-hand. The canonical EF-
hand co-ordinates the calcium ion via a pentagonal bipyramid i.e. through 7 
co-ordinating ligands (Figure 4A). The positions inside the 12 residue binding 
loop are referred to as: 
 
1(+X), 3(+Y), 5(+Z), 7(-Y), 9(-X), 12(-Z) 
 
Numbers indicate the position along the linear sequence of the loop whereas 
letters indicate the position in the 3D-geometry of the pentagonal bipyramid 
(Figure 4B). Amino acid residues in the Y and Z positions belong to the planar 
pentagon with a glutamic acid at -Z that provides two chelating groups as a 
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bidentate side chain. The X positions complete the coordination space for 
calcium and correspond to the tips of the bipyramid (47). 
 
 
Figure 4: Calcium coordination to the first EF-hand of calmodulin.  
Picture in (A) taken from (47). 
 
Although most chelating groups arise from the amino acid residues there is 
one exception found in the canonical EF-hand. This exclusion is displayed by 
position 7(-Y) that coordinates the calcium ion with its carbonyl group of the 
peptide backbone. Additionally the amino acid residue at position 9(-X) is able 
to coordinate the ion either directly or through a bridged water molecule. A 
hydrophobic amino acid residue at position 8 (Ile, Val or Leu) plays another 
important role: as mentioned before, EF-hands are usually found as pairs in 
EF-hand containing peptides and this residue stabilizes the paired EF-hand 
domain via a short anti-parallel β-sheet formed with the corresponding 
hydrophobic residue in the second EF-hand (48) (Figure 5). 
In contrast to the C2 domain many EF-hands display a structural 
rearrangement, elicited by the calcium coordination. The EF-hand pair 
undergoes a transition of almost parallel helices of each EF-hand in the apo 
(unbound or closed) state to perpendicular helices in the bound (open) state. 
In case of calmodulin this conformational change exposes a hydrophobic 
surface that is the basis of target recognition (47) (Figure 5). 
Some of the EF-hands are able to bind not only calcium but also magnesium. 
They are referred to as Ca2+/Mg2+ EF-hands. Two crucial features can be 
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observed in such EF-hands, namely a Z-acid pair (49) or an aspartic acid in 
position 12 (47). 
 
 
Figure 5: Structural change in EF-hands I and II of calmodulin upon calcium binding. 
Picture taken from (47). 
 
The coordination space for the magnesium ion exhibits an octahedral 
geometry thus in some of the Ca2+/Mg2+ EF-hands the bidentate amino acid 
residue at position 12 co-ordinates the ion through one of its oxygens, while 
calcium binding is promoted with both oxygens of the side chain. For example, 
in EF-hands III and IV of troponin C magnesium binding can induce a 
structural change and interferes with calcium binding (50, 51). 
According to their effector function essentially two categories of EF-hands can 
be discriminated: ‘regulatory’ EF-hands that undergo a conformational change 
after calcium binding and ‘structural’ EF-hands that do not (48). The regulatory 
hands are typical of proteins with important regulatory function such as 
calmodulin, troponin C or recoverin. These proteins usually mediate effects of 
calcium on physiology and biochemistry of a cell. The structural EF-hands 
occur in buffer proteins such as calbindin D9K or parvalbumin and serve to 
shape the profile and duration of calcium signals within cells. 
EF-hands generally occur as pairs in proteins that are stacked against each 
other and provide mutual stabilization. As a consequence, calcium binding to 
EF-hands is co-operative. In general positive co-operativity is observed 
because calcium binding to an EF-hand has positive structural effects on the 
‘partner’ hand, facilitating calcium binding to this hand. A certain challenge 
therefore may lie in tuning a sensor in a way that linear reporters of calcium 
and neuronal activity can be obtained. Due to the paired functional EF-hand 
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domain EF-hand containing polypeptides are often built in a modular fashion 
and have 2, 4, 6 or more EF-hand domains (52). Some of the smaller calcium 
binding proteins such as troponin C and calmodulin are constituted almost 
exclusively of 4 EF-hand motifs. Each pair of hands in these proteins form a 
globular lobe domain named the N-terminal and C-terminal lobe. The domains 
are structurally independent and differ considerably in terms of calcium 
binding properties and biological function (50, 53). The different nature of 
these domains should be kept in mind when using such a protein as binding 
domain within a biosensor. 
The strategy to develop genetically-encoded calcium indicators has followed 
two main ways. One set of indicators is based on a single chromophore 
whereas a second one uses FRET exploiting the GFP variants CFP and YFP. 
Typical members of the single chromophore indicators are the Camgaroos, 
Pericams, and GCaMPs that all rely on calmodulin (CaM) as calcium sensing 
domain.  
The Camgaroo family uses YFP (Camgaroo-1) (54) or Citrine (Camgaroo-2) 
(24) as fluorescent protein. The fluorophore has an insertion of Xenopus 
calmodulin at position Y145 that enables the modulation of fluorescence in a 
calcium dependent manner. The reported Kd values are 7 μM (Camgaroo-1) 
and 5.3 μM (Camgaroo-2) which list them amongst the low affinity calcium 
indicators.  
The Pericam family exploits a circularly permuted (cp) variant of YFP (at 
position 145). This cpYFP was fused between the M13 peptide and Xenopus 
CaM to yield a functional calcium indicator (55). The Kd values for calcium in 
this family vary between 0.2 μM - 1.7 μM which should make them suitable of 
detecting cytosolic calcium dynamics inside active neurons.  
In contrast to Pericams the GCaMPs are based on cpGFP (the same position 
is used namely amino acid 145). During the last years performance of this 
kind of GECI was improved yielding the state to the art GCaMP2 (56). The 
reported Kd is 146 nM which means that GCaMP2 is one of the most affine 
GECIs known so far.  
Beside single chromophore calcium indicators a number of various indicators 
exists that exploit the FRET-mechanism. For that purpose so far almost all of 
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these so-called ratiometric biosensors are using variants of the CFP and YFP 
since their fluorescence spectra show significant overlap (from donor emission 
and acceptor excitation) and excellent separation (of donor and acceptor 
excitation spectra) that allows for exclusive excitation of the donor without 
direct excitation of the acceptor (e.g. at 432 nm as depicted in Figure 6, black 
line). 
Ratiometric imaging has some advantages in contrast to single wavelength 
imaging. Instead of having an intensity change of a single wavelength, 
ratiometric indicators make use of fluorescence change in two channels. For 
CFP/YFP dependent calcium biosensors the binding of calcium usually 
promotes the FRET from CFP to YFP that can be detected by a decrease in 
intensity of the CFP and an increase in intensity of the YFP channel. 
 
 
Figure 6: Fluorescence excitation and emission spectra of CFP and Citrine. 
 
As readout the ratio of these two wavelengths is build and the relative change 
in their ratio reports the calcium binding to the indicator. Since two channels 
display the signal overall changes in fluorescence of both wavelengths, as 
elicited by movement or fluctuation of the excitation light source, cancel out 
yielding a more stable readout for the measurement. 
Among the FRET indicators two different calcium binding moieties are used. 
One group also exploits calmodulin whereas another family relies on troponin 
C. Since most of the calmodulin-based GECIs showed poor performance 
when they were used in in vivo experiments it has been thought that the 
calmodulin/M13 complex that exists in these sensors interact with the cellular 
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machinery particularly of neurons which in turn diminishes their activity (57). 
Therefore calmodulin was replaced by troponin C to build a second class of 
GECIs based on the FRET-mechanism that should not interfere with the 
cellular machinery.  
Calmodulin/M13 dependant ratiometric biosensors are the so called 
Cameleons among them Yellow Cameleon 2.0, 3.0 and 4.0 (YC 2.0, 3.0 and 
4.0) (40). YC 2.0 exploits wild type CaM, YC 3.0 the E104Q and YC 4.0 the 
E31Q mutation. Replacement of the acceptor protein YFP with Citrine (a pH 
stable YFP derivative, (24)) led to the variants YC 2.3, YC 3.3 and YC 4.3. As 
mentioned before FRET-efficiency depends not only on the distance but also 
on the orientation of the transition dipoles of the chromophores. This has been 
exploited in various FRET-based biosensors to increase the signal obtained 
with GECIs by introducing a circularly permuted acceptor protein (57, 58). In 
that respect the overall signal strength could be increased in the new sensors 
YC 2.60 (Kd is 40 nM), YC 3.60 (Kd is 250 nM) and YC 4.60 (Kd is 60 nM/14 
μM for the biphasic titration curve) (57).  
As mentioned before calmodulin-based indicators often did not show a good 
performance when they were expressed in the nervous system of transgenic 
animals (57). This is likely to be due to the fact that calmodulin plays an 
essential role in the cellular signaling machinery and that additionally 
expressed calmodulin or the calmodulin-target M13 peptide will interfere with 
this machinery and hence perturb the performance of calmodulin dependant 
GECIs. Additionally, overexpression of the CaM-peptide could promote 
activation of endogenous CaM-targets and disrupt the cellular homeostasis. 
Two different approaches emerged to circumvent theses problems. The group 
of Roger Tsien mutated the calmodulin and the M13 peptide inside the 
cameleons to prevent interaction with intrinsic binding partners yielding so-
called ‘design variants’ of Cameleons (D-series) (39). They could show that 
wild type calmodulin (CaM) does not diminish the overall signal strength of 
these indicators. For example the design variant D3cpv (Kd is 600 nM) retains 
90% of its ΔR/Rmax in the presence of 800 μM wild type CaM. This redesign 
should retain their functionality when expressed in the nervous tissue. A 
different way to avoid unwanted cellular/biosensor interactions was achieved 
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in our lab by replacing the calcium binding moiety of the cameleons with 
troponin C. This protein is exclusively expressed in the muscle tissue so that 
interaction with the cellular machinery inside neurons is unlikely to happen. 
The regulatory complex of muscle contraction consists of actin, tropomyosin 
and the troponin complex. The latter one consists of troponin C (TnC which 
binds Ca2+ and therefore displays the calcium sensor of the complex) together 
with troponin I (TnI that binds to actin and inhibits the actomyosin ATPase) 
and troponin T (TnT which links the troponin complex to tropomyosin). Binding 
of calcium to the N-terminal part of troponin C will remove the TnI inhibition of 
the ATPase, allowing subsequent hydrolysis of ATP and eventually the 
movement of the two filaments (actin and myosin) (59).  
 
 
Figure 7: Three dimensional structure of chicken skeletal troponin C. 
Figure was redrawn according to the pdb entry 1TOP. Calcium chelating loops are colored (loops of EF-
hand I and II in blue and loops of EF-hand III and IV in red). 
 
Troponin C consists of four EF-hands with two of them residing in each 
terminus (Figure 7). The protein displays a dumbbell-shaped occurrence 
consisting of about 160 amino acids with different calcium binding properties 
for each terminus. The N-terminal EF-hands (EF I and EF II) bind calcium with 
low affinity (Kd is 3 μM) and are insensitive to magnesium whereas the C-
terminal EF-hands (EF III and EF IV) bind calcium with high affinity (Kd is 50 
nM) and competitively bind magnesium (Kd is 0.2 mM) (49).  
One of the first troponin C-based indicators used a truncated (starting at 
leucine14) variant of chicken skeletal troponin C. This indicator named TN-
22 
Introduction 
L15 successfully expresses in mammalian cells and in transgenic animals 
where it reliably reports cytosolic calcium changes (41, 60, 61). Nevertheless 
improvement of TN-L15 with respect to signal strength and kinetics would be 
desirable. The most important characteristic of a given GECI is presumably 
signal strength i.e. the signal that is provided by the indicator at a given 
change in the calcium level. For example, it is important to have a GECI that 
is capable of sensing the small changes of cytosolic free calcium elicited by a 
single action potential which is not detected by TN-L15 (61).  
The aim of this research was to improve TN-L15 with respect to signal 
strength and hence to close the gap of non-responsiveness to small calcium 
changes. For that purpose different strategies were applied that ranges from 
point mutating the calcium binding domain of TN-L15 to profoundly 
rearranging the troponin C by doubling the C-terminal domain to yield an 
indicator that was suitable to detect single action potentials and sensory 
evoked calcium transients in vivo. 
 Material and Methods 
 
 
3.1. Molecular biology 
 
3.1.1. Polymerase Chain Reaction (PCR) 
 
Originally developed by Kary Mullis, this method allows the amplification of a 
distinct strand of DNA. For that purpose one makes use of a thermal-stable 
variant of DNA polymerase. This can be Taq (Thermus aquaticus), Vent 
(Thermococcus litoralis) or Pfu (Pyrococcus furiosus). The different enzymes 
vary in speed and accuracy of amplifying DNA. Pfu polymerase is known to 
have a high proof-reading capacity and is the choice for subsequent cloning.  
 
PCR-reaction mix (50 μl): 
 
0.5 - 1 μl DNA template (~50 ng) 
2 μl primer #1 (50 μM) 
2 μl primer #2 (50 μM) 
5 μl polymerase buffer (10 x) 
5 μl DMSO 
1 μl dNTP solution (12.5 mM) 
33 μl H2O 
0.7 μl Pfu polymerase (~2 U) 
 
Addition of DMSO to the reaction mix often enhances the yield of DNA 
obtained by the PCR especially when the reaction initially produces too little 
DNA. 
 
Reaction cycle: 
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1. 5 min at 95°C 
2. 30 s at 95°C     (melting of double stranded DNA) 
3. 2 min at 52°C   (annealing of primers) 
4. 2 min/1kb of target DNA at 68°C (synthesis of DNA) 
 
29x (2. - 4.) 
 
5. 5min at 68°C 
6. incubate at 15°C 
 
PCR-reaction mix was prepared on ice and put into thermal-cycler when a 
temperature of 95°C was reached.  
 
 
3.1.2. Site-directed mutagenesis via PCR 
 
Polymerase chain reaction can not only be used to amplify a defined stretch of 
DNA but is also suitable to introduce base substitutions. For that purpose a 
distinct base in the primer region is replaced by a different base so that in the 
translated protein one will find an amino acid replacement.  
Mutagenesis primers were designed in such a way that the replacing base 
resides in the middle of the oligonucleotide primer with an average length of 
~45 bases (roughly 7 triplets flanking the region to mutate on each side).  
 
Mutagenesis-reaction mix (50 μl): 
 
0.5 - 1 μl DNA template (5 - 50 ng) 
2.5 μl primer #1 (50 ng/μl) 
2.5 μl primer #2 (50 ng/μl) 
5 μl polymerase buffer (10 x) 
0.8 μl dNTP solution (12.5 mM) 
37.5 μl H2O 
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0.7 μl Pfu polymerase (~2 U) 
 
Reaction cycle: 
 
7. 30 s at 95°C 
8. 30 s at 95°C     (melting of double stranded DNA) 
9. 1 min at 55°C   (annealing of primers) 
10. 2 min/1kb of target DNA at 68°C (synthesis of DNA) 
 
16 x (2. - 4.) 
 
11.   5 min at 68°C 
12.   incubate at 15°C 
 
Usually mutation was achieved by applying the method to the target DNA in 
the pRSETB backbone. The whole vector was amplified and used to 
transform a bacterial strain of choice.  
To get rid of the template vector DNA, a DpnI digest was applied that 
degrades the methylated template DNA. 
 
DpnI-treatment: 
 
20 μl mutagenesis-mix 
1 μl DpnI (20 U) 
Incubate for 2 h at 37°C 
 
 
3.1.3. Restriction of DNA 
 
Restriction sites consist of a short sequence that usually comes along in a 
palindromic manner and have a length of 6 bp although longer restriction sites 
exist. These sites can be recognized by a specialized restriction 
26 
Material and Methods 
endonuclease that breaks the double strand and often leaves a single 
stranded (sticky) end. Restriction of DNA was used to prepare the vector 
backbone/PCR fragment for subsequent cloning or to analyze a given DNA for 
the correct introduction of a desired DNA-fragment after ligation.  
Control digests for checking the successful incorporation of a DNA stretch 
was done with 1 - 2 μl (100-200 ng) of DNA.  
 
1 - 2 μl DNA (100-200 ng) 
0.1 - 0.3 μl of restriction enzyme (~2 U) 
0.2 μl BSA (bovine serum albumine 100 x, NEB)  
2 μl restriction buffer for restriction enzyme (10 x, NEB) 
Add 20 μl H2O 
Incubate for 1 h at 37°C 
 
 
Preparative digests for subsequent cloning were performed as follows: 
 
2 - 10 μl DNA (2-10 μg) 
1 - 3 μl of restriction enzyme (~10 U) 
0.8 μl BSA (bovine serum albumin 100 x, NEB)  
8 μl restriction buffer for restriction enzyme (10 x, NEB) 
Add 80 μl H2O 
Incubate for 3 h - 16 h at 37°C (dependant on the restriction enzymes that 
were used and on the manufacturer’s advice [NEB]). 
 
 
3.1.4. Ligation of DNA fragments 
 
A prerequisite for an easy introduction of a new stretch of DNA into a vector 
backbone is to place different restriction site at each end of the desired DNA. 
Treatment of the vector backbone and the DNA of choice with the same set of 
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restriction enzymes enable the directed introduction of the desired fragment 
into the vector backbone.  
The molar ratio of vector to insert should be 1:3 to 1:5. Amount of DNA to use 
was determined by agarose gel electrophoresis of the desired DNA. 
 
0.5 - 1 μl vector DNA (~50 ng) 
1 - 3 μl insert (dependant of the size and concentration) 
1.5 μl T4 ligase buffer (10 x) 
0.75 μl T4 DNA ligase (300 U) 
Add 15 μl H2O 
Incubate for 1 h at room temperature 
 
 
3.1.5. Transformation of chemically-competent E. coli 
 
Chemically competent cells (50 μl aliquots, storage -80°C) were thawed on ice 
and transformed with desired DNA. Cells were kept on ice for 20 min and 
heat-shocked for 1 min in a water bath (42°C). Before striking out on LB-agar 
plates cells were additionally stored on ice for 2 min. When working with 
ampicillin resistance bacteria were immediately plated, for other resistance 
transformed bacteria were added with 150 μl of LB-medium and let grow 
without antibiotics for 1 h at 37°C in a shaker before plating onto LB-agar 
plates with the appropriate antibiotic.   
 
 
3.1.6. Transformation of electro-competent E. coli 
 
In order to increase the yield of transformed bacteria, one can make use of 
electroporation. For that purpose electro-competent cells were used as 
follows: put the desired DNA to electro-competent cells on ice. Place the cells 
into a pre-cooled cuvette and apply an electric pulse (1800 V). Add 150 μl of 
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SOC medium and let the bacteria grow for 1 h at 37°C in a shaker. Plate the 
suspension onto LB-agar plates supplemented with the appropriate antibiotic.  
 
 
3.1.7. Preparation of chemically-competent E. coli 
 
4 ml LB medium were inoculated with the desired strain of E. coli and grown 
overnight without supplementing with antibiotics. The next day culture was 
transferred into 300 ml LB medium and grown to an OD600 of 0.6. Next the 
suspension was placed on ice for 20 min followed by harvesting the cells by 
centrifugation at 2500 g for 20 min (4°C). Supernatant was discarded and the 
cells were resuspended with 60-80 ml of cooled Inoue transformation buffer. 
Again cells were harvested by centrifugation at 2500 g for 15 min (4°C). Once 
more cells were resuspended with cooled Inoue transformation buffer but this 
time with 20 ml supplemented with 1.5 ml DMSO. Suspension was incubated 
on ice for 10 min. Cells were aliquoted (50 μl) and stored at -80°C until usage. 
 
 
3.1.8. Preparation of electro-competent E. coli 
 
20 ml LB medium were inoculated with the desired strain of E. coli and grown 
overnight without supplementing with antibiotics. The next day culture was 
transferred into 1 l LB medium (37°C) and grown to an OD600 of 0.6. Next the 
suspension was cooled ice followed by harvesting the cells by centrifugation 
at 2500 g for 10 min (4°C). Supernatant was discarded and the cells 
resuspended with 50 ml of cooled H2O (sterile). This procedure was repeated 
5-6 times to remove all traces of ions. After the 4th washing step all cells were 
pooled into one 50 ml falcon tube. Eventually cells were resuspended with 4 
ml of cooled glycerol (10 %). Electro-competent E. coli were aliquoted (50 μl) 
and stored at -80°C until usage. 
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3.2. Proteinbiochemistry 
 
3.2.1. Protein expression using the E. coli BL21 strain 
 
DNA for the protein of interest was cloned in the pRSETB vector that is 
optimized for protein expression and carries a 6 x His-tag 5’ of the multiple 
cloning site. The vector containing the DNA of interest was transformed in the 
E. coli strain BL21. 5 ml of LB medium containing 10 μl of ampicillin (50 
mg/ml) were inoculated with 25 μl of the transformed bacterial culture. Starting 
culture was grown overnight at 37°C. The next day starter culture was used to 
inoculate 400 ml LB medium containing 50 μg/ml ampicillin. This bacterial 
culture was grown to an OD600 of 0.6 to 0.8 at 37°C and protein expression 
was induced with 0.5 mM IPTG (Isopropyl-β-D-Thiogalactosid) for 3 h at 37°C.  
Bacterial cells containing the protein were harvested by centrifugation at 6000 
g for 10 min (4°C). 
 
 
3.2.2. Purification of recombinantly expressed proteins 
 
Purification of the protein of interest was achieved via a fused N-terminal 6 x 
His tag that is capable of being chelated by a Ni-NTA column. Bacterial pellet 
was resuspended with 10 ml of protein resuspension buffer supplemented 
with 1 mM PMSF, 5 μg/ml Pepstatin and 1 μg/μl Leupeptin to inhibit protease 
activity. Resuspension was put to a freezer (-80°C) for 10 min to induce cell 
lysis. After thawing, 1 mg of lysozyme was added to break up the bacterial cell 
wall (30 min on ice). In a next step 0.1 % Trition-X-100, 5 μg/ml DNAseI and 5 
μg/ml RNAse were added and lysis was proceed in an ultrasound bath 
containing ice for 20 min. Protein was harvested by centrifugation for 30 min 
at 13.000 rpm. Supernatant containing the protein of interest was removed 
and 300 μl of Ni-NTA agarose was added. Binding was allowed for 2 h at 4°C. 
For purification the bound protein/Ni-NTA agarose suspension was put in a 
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polypropylene column and exposed to gravity. Suspension was washed with 
20 ml of column washing buffer containing 10 mM of imidazole. Protein was 
eluted by replacing the bound protein with imidazole using column elution 
buffer containing 150 mM imidazole. 
 
 
3.3. Spectroscopy 
 
3.3.1. Fluorescent spectra of purified proteins 
 
Fluorescent spectra were taken using a fluorescent spectrophotometer. 
Purified proteins were diluted in MOPS (10 mM) buffer containing 100 mM KCl 
and 25 μM EGTA to set the free ion concentration to zero. CFP/YFP FRET 
constructs were excited at 432 nm (bandwidth 5 nm) and the emission was 
recorded from 450 nm to 600 nm (bandwidth 5 nm). After taking the Ca2+-free 
spectrum the indicator was exposed to different values of free ion 
concentrations (e.g. 1 mM Mg2+ or 10 mM Ca2+) by adding the appropriate 
amount of MgCl2 or CaCl2. Again an emission spectrum was taken. To 
calculate the ΔR/R value elicited by a given ion the following formula was 
used: 
 
[ ] 100
 Ratio
 Ratio - Ratio 
   % R/R
ion zero
ion zeroion value desired
ion value desired ∗=Δ  
 
where Ratio = PeakYFP/PeakCFP (527nm/432nm). 
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3.3.2. Spectroscopic determination of Kd-value  
 
For determination of Kd-value only freshly purified protein was used. For 
titration a prewarmed (room temperature) titration kit was applied as follows. 
Two stock solutions were prepared: 
• Zero calcium: mix 1ml of zero calcium buffer with 1 volume of 
protein solution (~0.2 - 1 μM protein, directly in cuvette) 
• High calcium: mix 5.4 ml of 39.8 μM free calcium buffer with 5.4 
volumes of protein solution (use a 15 ml Falcon tube) 
Subsequently the zero calcium stock was put into the fluorescence 
spectrophotometer to take a spectrum of baseline. Excitation wavelength for a 
CFP/YFP FRET-pair again was 432 nm.  The emission was determined in the 
range from 450 nm to 600 nm (all bandwidths 5 nm).  
Adjustment of the free calcium values was achieved by reciprocal dilution 
(replacing same amount of zero calcium buffer with the high calcium stock) to 
the desired concentrations. Usually 0, 0.065, 0.100, 0.225, 0.350, 0.600, 
0.850, 1.35, 1.73, 2.85, 4.87, 7.37, 14.9, 29.9 and 39.8 μM free calcium was 
used as reference points to determine the Kd-value. Calculation of the 
volumes that had to be replaced was along the manufacturer’s manual 
(http://probes.invitrogen.com/media/pis/mp03008.pdf).  
 
CaEGTA  
[mM] 
Free Ca2+  
[μM] 
Volume to replace 
[μl] 
0.00 0.000  
3.00 0.065 300 
4.00 0.100 143 
6.00 0.225 333 
7.00 0.351 250 
8.00 0.602 333 
8.50 0.853 250 
9.00 1.35 333 
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9.20 1.73 200 
9.50 2.85 375 
9.70 4.87 400 
9.80 7.37 333 
9.90 14.9 500 
9.95 29.9 500 
10.0 39.8 1000 
 
After taking the spectra the ΔR/R at distinct calcium concentrations was 
calculated. 
Extraction of the Kd-value was achieved by fitting a sigmoidal curve to the 
plotted log10 values of the free calcium points (in M) versus the normalized 
signal (normalized to 39.8 μM free calcium). For this purpose OriginLab 7.5 
was used. 
 
 
3.3.3. Stopped-flow measurements  
 
Experiments were carried out in a Varian Cary Eclipse Fluorescence 
Spectrophotometer with an Applied Photophysics RX Pneumatic Drive 
Accessory. Two stock solutions were prepared as follows: 
• Calcium saturated indicator (5 ml): 10 mM MOPS, 4 mM CaCl2, 
2 mM MgCl2, 50 mM KCl, ~0.2 - 1 μM indicator pH 7.5 
• BAPTA solution (5 ml): 10 mM MOPS, 50 mM KCl, 20 mM 
BAPTA pH 7.5 
Two separate 5 ml syringes were filled with both solutions and the stopped-
flow experiment was performed at room temperature (injection pressure 3.5 
bar). Excitation of the indicator was again set to 432 nm (bandwidth 5 nm). 
Emission spectra of the two individual channels were taken in an alternated 
manner at 475 nm (for CFP, bandwidth 10 nm) and 527 nm (for YFP, 
bandwidth 10 nm) respectively. Acquisition time was set to 12.5 ms, duration 
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to >10 s, mixing volume to 400 μl with a mixing dead time of the instrument of 
8 ms. 
An average of the individual channel was built and a resulting YFP/CFP ratio 
was calculated. To determine the decay time value the resulting 527 nm/475 
nm ratio decay was fitted with a single or double-exponential using OriginLab 
7.5. For calculation of the ratio decay, each channel was recorded at least 
nine times. This procedure was repeated three times with independently 
purified proteins.  
 
 
3.4. Cell culture 
 
3.4.1. Preparation of dissociated hippocampal neuronal culture  
 
E18 pregnant Wistar rats were killed using CO2. Embryos were obtained by 
removing the uterus and placing it into a Petri dish filled with PBS. By opening 
the skull, brains were excised and placed into cold HBSS. After removing the 
meninges the region of the hippocampus was prepared and placed into HBSS 
containing 1 mg/ml dispase for 20 min at 37°C. Subsequently the medium 
was replaced with the same volume of DMEM/10 % FCS. By triturating the 
solution the tissue was finally dissociated. 
For cultivating the cells, glass-bottom culture dishes (35 mm, MatTek) were 
incubated overnight with Poly-L-Lysine. The next day dishes were washed 
with PBS and filled with 2 ml of DMEM/10 % FCS and placed into the 
incubator (37°C; 5 % CO2). Freshly triturated cells were plated into the culture 
dishes overnight. The next day medium was replaced by Neurobasal 
supplemented with B27. Neurons were kept up to 4 weeks by changing the 
medium every week.  
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3.4.2. Transfection of neuronal cell culture using lipofectamine 
 
Delivering DNA of interest to neuronal cell cultures can be achieved using the 
lipofectamine approach. For that purpose 2 μg of plasmid DNA were solved in 
250 μl of Opti-MEM I. In parallel 10 μl of Lipofectamine were mixed with 250 μl 
of Opti-MEM I and this mixture was incubated for 5 min at room temperature. 
After this incubation time the DNA-mix and the Lipofectamine-mix were 
combined and let stand for additional 20 min. Eventually 500 μl of the mix 
were added to the neuronal cell culture and the transfection was allowed to 
proceed for 2 - 3 hours (37°C, 5% CO2). After the incubation, cells were 
washed with 1 volume of Neurobasal medium.  
 
 
3.4.3. Transfection of neuronal cell culture using phosphate-
precipitation 
 
To drive expression of the indicator in neuronal cell culture, the calcium 
phosphate precipitation method was used. For that purpose 100 μl of CaCl2 
(250 mM) were mixed with 10 μg of plasmid DNA and 100 μl of 2x BBS. The 
mix was incubated for 20 min. From the cell culture 500 μl of conditioned 
medium was put aside before the DNA was added (all 200 μl per 35 mm 
dish). Subsequently the cells were placed back to the incubator and 
transfection was allowed to proceed for 2-3 hours. After transfection was 
completed the dishes were rinsed 2 - 3x with prewarmed Neurobasal medium 
to remove the residual precipitates. Next 1.5 ml of Neurobasal medium and 
0.5 ml of the conditioned medium were added to the dishes.    
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3.5. Imaging Setup 
 
Imaging experiments were performed on a Zeiss Axiovert 35M fluorescence 
microscope including a 40x objective. Setup was controlled by a Metafluor 4.6 
imaging software. For excitation, the light of a xenon lamp passed a 440/20 
nm excitation filter. Fluorescence of the individual channels was collected 
subsequently through two emission filters placed in a filterwheel (485/35 nm 
for CFP and 535/25 nm for Citrine cp174). Acquisition time was set to 500 ms 
per channel and every channel was imaged with a frequency of 0.5 Hz. 
 
 
3.6. Transgenic animals 
 
3.6.1. Transgenic flies 
 
The elavC155-Gal4 and elav-Gal4 driver lines allow expression of the indicators 
in the whole nervous system. In the line elavC155-Gal4, the elav promoter is 
fused to Gal4 that is located on the X-chromosome. 
 
 
3.6.1.1. Spin dialysis 
 
The DNA has to be cleaned by spin dialysis before injection. Little columns 
were prepared by cutting the lid of plastic tubes and poking a hole in the 
bottom with a thin needle. The tube was filled with 25 μl of glass beads and 
placed into a second tube. It was filled with 10 x Sepharose CL6B and 
centrifuged at 3000 rpm for 3 minutes. Subsequently the second tube was 
replaced by a fresh one. DNA was incubated at 65ºC for 10 min and applied 
carefully onto the glass beads and centrifuged at 3000 rpm for 3 min. DNA-
precipitation and injection mix spin dialysed DNA (approx. 6 μg) and spin 
dialysed Δ2 - 3 (approx. two μg) were diluted in 100 μl H2O. For precipitating 
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the DNA mix, 1/10 % vol. of 3 M NaAcetat was added to the solution. After 
mixing, 2.5 x  EtOH (100 %) was added and the sample was incubated in a 
freezer at -70ºC for 30 min and centrifuged at 15 000 rpm for 30 min. The 
supernatant was discarded and the sample washed with 100 μl 70 % EtOH. 
After centrifugation at 15 000 rpm for 30 min, supernatant was discarded and 
the DNA was dried by exposing to air. The DNA was diluted in 20 μl 1 x 
injectionbuffer. 
 
 
3.6.1.2. Injection of fly embryos with DNA 
 
Wildtype flies (Bayreuth w-) were collected in a collection tube placed on apple 
agar plates and held overnight at room temperature with light. The apple agar 
plate was changed every 30 min and the laid eggs collected. After washing of 
eggs with PBT, they were put in Klorix for three minutes to remove the 
chorion. As a next step they were washed again with PBT and rowed up in a 
line on a piece of apple agar. A coverslip coated with custom made glue 
based on tape and heptan was pressed on the eggs to pick them up. 
A glass electrode was filled with Voltalef 3S oil and the injection mix was 
sucked in. The strung embryos were dried in silica gel, covered with Voltalef 
10S oil and put under the microscope. Small amounts of injection mix were 
injected into the dorsal part of the eggs by exerting pressure on the syringe. 
The DNA was inserted in the genome of the germ line cells by p-element 
mediated transfection (62). After injection, embryos were placed on apple 
agar plates and incubated at 18ºC until the embryos developed to larvae. The 
larvae were collected and put in a vial containing food until the flies hedged. 
 
 
3.6.1.3. Generation of transgenic fly stocks 
 
Every single male fly that hedged from the injected embryos was crossed to 
10 wild type virgins. The progeny was screened for colored eyes and single 
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flies were crossed to the balancer line rl/Sm6Tm6 that carries the two markers 
‘curly wings’ and ‘tubby larvae’ on a fused 2nd and 3rd chromosome. The 
hedging flies were transferred into a new vial to breed a new fly stock. 
 
 
3.6.1.4. Crossing 
 
Five to ten virgin female elavC155-Gal4-driver flies were crossed to three male 
flies carrying UAS-TN-XXL. They were put in a vial containing fly food and 
yeast. Because D. melanogaster adults do not mate for about 10 hours after 
eclosion, virgin females can be obtained by collecting them within 8 - 10 hours 
after the vial has been cleared from adults. 
 
 
3.6.1.5. Breeding and husbandry 
 
About 5 female and 5 male flies were collected in vials containing food and 
yeast. Generation time (from egg to adult) takes approximately seven days at 
29ºC, nine days at 25ºC, eleven days at 22ºC, 19 days at 18ºC (source: 
Bloomington stock center). 
 
 
3.6.2. Transgenic mice 
 
3.6.2.1. DNA preparation for pronucleus injection 
 
The genetically-encoded calcium indicators TN-XL and TN-XXL were 
subcloned into the (human) hGFAP_CFP plasmid by replacing the CFP 
coding sequence (plasmid kindly provided by Frank Kirchhoff). For that 
purpose the restriction sites AgeI (5’) and EcoRI (3’) were used. Linearization 
of the promoter/indicator DNA was achieved by overnight digestion of ~40 μg 
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plasmid DNA with DrdI. Purification was performed by agarose gel 
electrophoresis followed by electroelution into a Spectra/Por dialysis 
membrane. An additional ion exchange purification step was applied using an 
Elutip-D Minicolumn. After equilibration of the column for 1 h with Low Salt 
DNA Purification Buffer, the DNA was bound to the column. After washing 
with Low Salt Buffer, elution of the linearized DNA was achieved with the High 
Salt DNA Purification Buffer. For injection, DNA was adjusted to 100 ng/μl. 
 
 
3.6.2.2. Injection and breeding  
 
Microinjection of purified DNA was in pronuclei of mouse oocytes performed 
by the Transgenic Service Facility of the MPI for Biochemistry in 
Martinsried/Germany. Strains for oocyte injection were FVB and FVB:C57BL/6 
(F1-hybrids) which have large oocytes and therefore allow a high percentage 
of transgenes (63). 
 
 
3.6.2.2. Genotyping 
 
Purification of genomic DNA for PCR was achieved with the Proteinase 
K/isopropanol precipitate method of mouse tail tissue. Roughly 5 mm of tail 
tissue was removed from each individual mouse and dissolved in 250 μl of 
Mouse Tail Lysis Buffer 55ºC (overnight). The next day dissolved mouse tails 
were centrifuged for 6 min in an Eppendorf microcentrifuge to pellet the 
debris. Subsequently the supernatant was placed into new eppendorf reaction 
tubes and the DNA was precipitated with equal amount of ispropanol. 
Precipitated DNA was again centrifuged and the supernatant was discarded 
followed by drying for 1 h at 50ºC in a heating block. As final step the DNA 
was dissolved in 200 μl TE buffer and incubated overnight at 4ºC.  
PCR for genotyping was performed as follows (one reaction): 
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0.5 μl DNA 
0.2 μl dNTP (12.5 mM) 
0.6 μl GFAP_for (20 μM) 
0.6 μl CFP_Chr_rev (20 μM) 
0.3 μl IL-2_for (20 μM) 
0.3 μl IL-2_rev (20 μM) 
1.2 μl Taq Polymerase Buffer (10x, NEB) 
0.5 μl Taq Polymerase (5 U/μl) 
7.3 μl H2O 
 
Reaction mixture was prepared on ice and subsequently placed into the 
preheated thermal cycler. PCR was performed as follows: 
 
1. 1 min 30 s at 94°C 
2. 30 s at 94°C 
3. 1 min at 60°C 
4. 30 s at 72°C 
5. go to step 2 for 35 times 
 
10°C forever 
 
Primers: 
 
GFAP_for  5’- CTC GCG GGG ATC CTC TAG-3’ 
CFP_Chr_rev 5’- TGC ACG CCC CAG GTC AG-3’ 
 
IL-2_for  5'-CTA GGC CAC AGA ATT GAA AGA TCT-3' 
IL-2_rev  5'-GTA GGT GGA AAT TCT AGC ATC ATC C-3' 
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3.7. Materials 
 
 
3.7.1. Instruments 
 
Name Supplier 
Autoflow CO2 Water-Jacketed Incubator NuAire, Plymouth (USA) 
Cary 100 Scan UV-Visible 
Spectrophotometer 
Varian, Mulgrave (Australia) 
Cary Eclipse fluorescence 
spectrophotometer 
Varian, Mulgrave (Australia) 
CCD-Camera Cool Snap HQ Roper Scientific, Tucson (USA) 
Dissecting Microscope Leitz, Stuttgart (Germany) 
Dyad DNA Engine Peltier Thermal 
Cycler 
MJ Research Inc., Waltham (USA) 
Metafluor 4.6 imaging software Universal Imaging, Downingtown (USA) 
Microscope Axiovert 35M Zeiss, Oberkochen (Germany) 
Shutter Lambda 10-2 Sutter Instruments, Novato (USA) 
Stopped Flow RX2000 Rapid Kinetics 
Accessory Unit 
Applied Photophysics, Leatherhead (UK) 
 
 
3.7.2. Consumables 
 
Name Supplier 
Domed Cap Strips for 48 Well Plates AB-Gene, Epsom (UK) 
Eartags for mice, Monel Nr. 1005-1 National Band & Tag Company, Newport 
(USA) 
Elutip-D Minicolumns Schleicher & Schüll, Keene (USA) 
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Falcon Tissue Culture Plate, 12 Well Becton Dickinson, Franklin Lakes (USA) 
Glass Bottom Culture Dishes 35mm, Nr. 
P35G-0-14-C 
MatTek Corp., Ashland (USA) 
Polypropylene Columns Qiagen, Hilden (Germany) 
QIAquick Gel Extraction Kit Qiagen, Hilden (Germany) 
QIAquick PCR Purification Kit Qiagen, Hilden (Germany) 
Spectra/Por Dialysis Membrane, MWCO 
3500, Nr. 132111 
Spectrum Labs Inc., Rancho Dominguez 
(USA) 
 
 
3.7.3. Buffers, solutions and media 
 
Name Recipe 
BAPTA Buffer for dissociation kinetics 10 mM MOPS, pH 7.5 
50 mM KCl 
20 mM BAPTA 
BBS (2 x) 50 mM BES (acid), pH 6.96 
280 mM NaCl 
1.5 mM Na2HPO4 
CaCl2 solution for phosphate 
transfections 
250 mM CaCl2 in H2O 
DMEM/10 % FCS 500 ml DMEM 
50 ml FCS, heat-inactivated 
DNA Gel Loading Buffer (10 x) 100 mM Tris/HCl, pH 7.5 
10 mM EDTA 
50 % Glycerol 
1 % Orange G 
DNA Purification Buffer: High Salt 20 mM Tris/HCl, pH 7.4 
1 M NaCl 
1 mM EDTA 
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Name Recipe 
DNA Purification Buffer: Low Salt 20 mM Tris/HCl, pH 7.4 
200 mM NaCl 
1 mM EDTA 
Fly Injection Buffer (10 x) pH 6,8 0,2 ml 0,5 M NaPi 
5 ml 1 M KCl 
94,8 ml H2O 
Glue (based on heptan) Tape (Tesa) in 50 ml n-Heptan 
HBSS for imaging 25 mM HEPES pH 7.4 
140 mM NaCl 
5 mM KCl 
1 mM CaCl2 
1 mM MgCl2 
1 mM Glucose 
0.25% BSA 
HBSS with high KCl for imaging 25 mM HEPES, pH 7.4 
40 mM NaCl 
100 mM KCl 
1 mM CaCl2 
1 mM MgCl2 
1 mM Glucose 
0.25% BSA 
Inoue Transformation Buffer for 
competent cells 
10 mM PIPES, pH 6.7 
250 mM KCl 
15 mM CaCl2 
55 mM MnCl2 
LB (Luria-Bertani) medium 
pH 7,0 
20 g/l LB broth base 
in ddH20 
LB Agar LB Medium 
15 g Agar 
in 1 l ddH2O 
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Name Recipe 
Mouse Tail Lysis Buffer 100 mM Tris/HCl, pH 8 
250 mM NaCl 
1 mM EDTA 
0.2% SDS 
200 µg/ml Proteinase K added freshly 
MOPS Buffer for fluorescence 
spectroscopy 
10 mM MOPS, pH 7.5 
100 mM KCl 
Neurobasal/B27  500 ml Neurobasal medium 
10 ml B27 supplement 
PBS (10 x) 100 mM Na2HPO4, pH 7.4 
20 mM KH2PO4 
1.37 M NaCl 
27 mM KCl 
PBT (1 x) 0.05 % Triton X-100 
in 1x PBS 
Poly-L-Lysine 0.01 % (w/v) Poly-L-Lysine 
Hydrobromide in H2O 
Protein Buffer for dissociation kinetics 10 mM MOPS, pH 7.5 
50 mM KCl 
4 mM CaCl2 
2 mM MgCl2 
Protein Resuspension Buffer 20 mM NaPO4, pH 7.8 
300 mM NaCl 
TAE (10 x) 48.4 g Tris base 
11.4 ml glacial acetic acid 
20 ml of 0.5 M EDTA, pH 8.0 
add H2O to 1 liter 
TAE (1 x) 40 mM Tris-acetate 
1 mM EDTA 
TE (1 x) 10 mM Tris/HCl, pH 8.4; 1 mM EDTA 
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3.7.4. Chemicals 
 
Name Supplier 
Agar Sigma, St. Louis (USA) 
Ampicillin, sodium salt Roth, Karlsruhe (Germany) 
BAPTA, AM-ester Molecular Probes, Eugene (USA) 
BAPTA, tetrapotassium salt Molecular Probes, Eugene (USA) 
BES Roth, Karlsruhe (Germany) 
Bovine Serum Albumin (BSA) Sigma, St. Louis (USA) 
Calcium Calibration Buffer Kit with 
Magnesium #1 
Molecular Probes, Eugene (USA) 
Calcium Chloride, dihydrate Sigma, St. Louis (USA) 
Carbachol Sigma, St. Louis (USA) 
Deoxyribonuclease Sigma, St. Louis (USA) 
Dispase Gibco, Grand Island (USA) 
Dithiothreitol Sigma, St. Louis (USA) 
DMSO (Dimethylsulfoxide) Sigma, St. Louis (USA) 
Dulbecco's modified Eagle's medium 
(DMEM) w/o Sodium Pyruvate;  
w/ 4500 mg/ml Glucose;  
w/ Pyridoxine-HCl 
Invitrogen, Carlsbad (USA) 
Dulbecco's modified Eagle's medium 
/F12 
Invitrogen, Carlsbad (USA) 
EGTA (Ethylene glycol bis(beta-amino 
ethyl ether tetra-acetic acid) 
Sigma, St. Louis (USA) 
Fetal Bovine Serum Gibco, Grand Island (USA) 
Glucose (D-(+)-Glucose anhydrous, min 
99%) 
Sigma, St. Louis (USA) 
Glycine Merck, Darmstadt (Germany) 
HEPES free acid Sigma, St. Louis (USA) 
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Name Supplier 
Imidazole  Merck, Darmstadt (Germany) 
Ionomycin, calcium salt Sigma, St. Louis (USA) 
Leupeptin hydrochloride Sigma, St. Louis (USA) 
L-Glutamic acid Roth, Karlsruhe (Germany) 
Lipofectamine Invitrogen, Carlsbad (USA) 
Lysozyme Sigma, St. Louis (USA) 
Magnesium chloride hexahydrate Merck, Darmstadt (Germany) 
MES monohydrate Sigma, St. Louis (USA) 
MOPS Merck, Darmstadt (Germany) 
NeuroBasal medium Gibco, Grand Island (USA) 
Ni-NTA Agarose Qiagen, Hilden (Germany) 
Opti-MEM I Invitrogen, Carlsbad (USA) 
Penicillin-Streptomycin Gibco, Grand Island (USA) 
Pepstatin A Sigma, St. Louis (USA) 
Pfu polymerase Stratagene, La Jolla (USA) 
Phenylmethylsulfonylfluoride (PMSF) Sigma, St. Louis (USA) 
Poly-L-lysine hydrobromide Sigma, St. Louis (USA) 
Potassium chloride Merck, Darmstadt (Germany) 
Ribonuclease A Sigma, St. Louis (USA) 
Saccharose Merck, Darmstadt (Germany) 
Sepharose CL6B Sigma, St. Louis (USA) 
Sodium bicarbonate Sigma, St. Louis (USA) 
Sodium chloride Sigma, St. Louis (USA) 
Sodium phosphate monobasic, 
anhydrous 
Sigma, St. Louis (USA) 
T4-Ligase New England Biolabs, Beverly (USA) 
Triton-X-100 Sigma, St. Louis (USA) 
Trizma Base Sigma, St. Louis (USA) 
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Name Supplier 
Trypsin Sigma, St. Louis (USA) 
Trypsin-EDTA Gibco, Grand Island (USA) 
Voltalef 3S oil Lehmann & Voss & Co., Hamburg 
(Germany) 
Yeast extract Sigma, St. Louis (USA) 
 
 
3.7.5. Plasmids, bacterial strains, cell-lines and flies 
 
Plasmid name Supplier 
pcDNA3 Invitrogen, Carlsbad (USA) 
pRSETB Invitrogen, Carlsbad (USA) 
Strain name Supplier 
BL21(DE3) Invitrogen, Carlsbad (USA) 
DH5α Invitrogen, Carlsbad (USA) 
XL-1 Blue Invitrogen, Carlsbad (USA) 
HEK 293T Invitrogen, Carlsbad (USA) 
Fly strain Provider and engineer 
WT Bayreuth w- provided by C. Lehner, University of 
Bayreuth (Germany) 
elavC155-Gal4 gift from C. S. Goodman, University of 
California Berkeley, Berkeley (USA) 
(64) 
 
 
 
 Results 
 
 
4.1. Development of TN-XL, a Mg2+-insensitive GECI based on 
troponin C with fast kinetics 
 
 
In order to enhance FRET signals in troponin C-based calcium biosensors I 
have made use of the circularly permuted (cp) protein variants. These variants 
display the same structural geometry as the wild type protein but have 
different N- and C-termini. In cp variants the linear sequence of the wild type 
protein is broken up at one site and the resulting parts are exchanged yielding 
a protein with new C- and N-termini. Using a distinct variant of the acceptor 
protein Citrine, namely Citrine cp174, I could enhance FRET-efficiency in TN-
L15 Citrine cp174 and thereby enhance the signal strength of this indicator 
presumably due to the reorientation of the transition dipoles of the two 
chromophores (58). Unfortunately signal enhancement was not confined to 
calcium-induced signals but was also seen with magnesium. In the following 
chapter, I will present the strategy applied to circumvent magnesium binding 
to the TnC backbone of our GECIs to retain a high fractional fluorescent 
change elicited exclusively by the calcium ion. 
 
 
4.1.1. Removing Mg2+-induced FRET signals in troponin C-based 
GECIs 
 
As mentioned in the introduction, troponin C is capable of not only binding 
calcium but also magnesium. For this reason TN-L15 Citrine cp174 shows an 
enhanced signal produced by 1 mM Mg2+ in contrast to the signal elicited by 
the same amount of Mg2+ in TN-L15 (Figure 8).  
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Figure 8: Fluorescence emission spectra of TN-L15 and TN-L15 Citrine cp174, two 
troponin C-based GECIs. 
Spectra were recorded in MOPS buffer supplemented with 25 μM EGTA/100 μM EDTA to set free 
calcium and magnesium to zero (black lines). Excitation took place at 432 nm and emission was 
recorded from 450 nm to 600 nm (all bandwidths 5 nm). Red lines correspond to magnesium-induced 
FRET after adding 1 mM of MgCl2 to the solution. Note that the magnesium-induced signals are more 
pronounced in TN-L15 Citrine cp174. Signals obtained after saturating the indicators with 10 mM CaCl2 
are indicated with blue lines. All spectra are normalized to the isosbestic point at 514 nm. 
 
 
 
Figure 9: Ribbon and stick representation of the calcium binding loops III and IV in 
csTnC. 
Shown are the chelating positions in each of the C-terminal calcium binding loops. Amino acids in TN-
L15 Citrine cp174 chosen for mutagenesis are highlighted (Asn108, Asp110, Asn144 and Asp146). 
Structures were redrawn according to the pdb entry 1TOP using DeepView/SwissPdbViewer 3.7. 
Ribbon representation of the protein backbone is depicted in yellow. 
49 
Results 
 
 
Figure 10: Fluorescence emission spectra of different variants with disrupted Z-acid 
pairs of EF-hand III and IV. 
Overview of the development to remove magnesium-induced FRET signals in TnC-based calcium 
indicators. As seen in Figure 8 TN-L15 Citrine cp174 exhibit a huge signal with 1 mM Mg2+. Subsequent 
disruption of the Z-acid pair in the loop region of EF III and IV yielded indicators with reduced 
magnesium-induced signals. TN-L15 Citrine cp174 N108D D110N and TN-L15 Citrine cp174 N144D 
D146N correspond to indicators in which only one binding loop is mutated (EF III and EF IV 
respectively). Almost no magnesium-induced FRET is detectable in the double mutant TN-L15 Citrine 
cp174 N108D D110N N144D D146N (TN-XL). Again spectra were obtained by exciting the indicators at 
432 nm and recording the emission from 450 nm to 600 nm. Black curves correspond to the ion-free 
indicator at 25 μM EGTA/100 μM EDTA. Magnesium- (red curve) and calcium- (blue curve) induced 
FRET signals were obtained by adding 1 mM MgCl2 and 10 mM CaCl2. All spectra are normalized to the 
isosbestic point at 514 nm. 
 
To avoid magnesium-induced FRET signals I introduced different point 
mutations in the calcium binding domains EF III and EF IV of chicken skeletal 
troponin C in TN-L15 Citrine cp174. These mutations disrupt the Z-acid pair 
relying in each EF-hand’s calcium binding loop and at the same time restore 
the overall amount of negatively charged amino acid residues. It has been 
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shown that a Z-acid pair plays an important role in chelating the magnesium 
ion (49). The particular mutations refer to N108D/D110N for EF-hand III and 
N144D/D146N for EF-hand IV (Figure 9). Positions depicted in this thesis 
refer to the sequence of chicken skeletal troponin C according to the NCBI 
accession number NM_205450. Numbering of the amino acids starts with 
alanine1, the first residue that is encoded after the initial start codon for 
methionine. 
I introduced all variations of the mutated EF-hands into the TN-L15 backbone, 
leading to indicators named TN-L15 Citrine cp174 N108D D110N (EF III 
mutated), TN-L15 Citrine cp174 N144D D146N (EF IV mutated) and TN-L15 
Citrine cp174 N108D D110N N144D D146N (both hands mutated). The 
purified indicator proteins displayed different magnesium-induced signals but 
always showed a significantly reduced FRET elicited by Mg2+ according to 
TN-L15 Citrine cp174 (Figure 10). 
Disruption of the Z-acid pair in EF III lead to the lowest magnesium-induced 
FRET signal in the two sensors where just one calcium binding loop was 
mutated. Best performance was achieved by mutating both EF-hands.  
 
 
Figure 11: Schematic of the substitutions in the calcium binding loops III and IV in TN-
XL. 
Shown is the C-terminal part of csTnC from leucine98 to phenylalanine154. Yellow boxes highlight the 
chelating loops of EF-hand III and IV of csTnC. In the blow up boxes the chelating residues of TN-XL 
are compared to TN-L15. In TN-XL the Z-pair consists of an asparagine/glutamic acid which refers to 
the disrupted Z-acid pair. 
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The indicator TN-L15 Citrine cp174 N108D D110N N144D D146N displayed 
almost no magnesium-induced signal thereby providing a huge ΔR/Rmax 
elicited by calcium in the presence of magnesium. Therefore it was named 
TN-XL (for X-Large). Figure 11 shows a schematic of the substitutions that 
were made according to the TN-L15 backbone. Shown is the C-terminal part 
including the ion binding loops of EF-hand III and IV. 
 
 
4.1.2. Characteristics of TN-XL 
 
In the next step TN-XL was characterized with respect to its dissociation 
constant (Kd) and decay time constant (τ). To determine the Kd-value of TN-
XL we used a commercially available calcium titration kit that is supplemented 
with 1 mM free Mg2+. Figure 12A shows the result of four different titrations 
performed on four independently purified TN-XL proteins. A dose response 
curve fit to the data in Figure 12A yielded a calcium dissociation constant for 
TN-XL of 2.2 μM (in presence of 1 mM free magnesium). 
 
 
Figure 12: Characteristics of TN-XL. 
(A) Calcium titration curve for determination of the dissociation constant. Data points reflect the average 
of four titrations from four different purified proteins. Dose response fit to the data yielded a Kd for TN-
XL of 2.2 μM. (B) Stopped-flow measurement for determination of the decay time constant of TN-XL. 
Data represent the average 527 nm/475 nm decay of three measurements. In each experiment the ratio 
decay was calculated by averaging the CFP rise and YFP decay from at least nine runs. Resulting τ was 
180 ms for single exponential fit and 143 ms (91 %)/864 ms (9 %) for double exponential fit. Inset shows 
a blowup of the first three seconds. 
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Aside from the calcium range where a given indicator displays its dynamic 
range, kinetics are of particular interest. The decay time constant of calcium 
saturated (2 mM Ca2+, 1 mM Mg2+) TN-XL indicator protein was determined 
by a stopped-flow experiment. Rapid mixing of the indicator with 10 mM 
BAPTA led the indicator return to the calcium-free state. This was displayed 
by a decrease in the Citrine cp174 channel and an increase in the CFP 
channel. Figure 12B shows the resulting mean 527 nm/475 nm ratio decay 
extracted from three independently purified proteins (with at least nine 
measurements per channel). Resulting dissociation time constants are 180 
ms (for single exponential fit) and 143 ms/864 ms (for double exponential fit) 
and represent the Koff since [BAPTA] >> [indicator] and Kd (BAPTA) << Kd 
(indicator). Inset in Figure 12B shows a blow up of the first 3 seconds. 
 
 
4.1.3. Expression of TN-XL in cultured hippocampal neurons 
 
To test the in vitro performance of TN-XL primary hippocampal neurons were 
transfected with either the TN-XL or TN-L15 constructs. Before this could be 
performed both constructs were subcloned into the pcDNA3 vector to allow 
cytosolic expression that is driven by the CMV promoter. Both indicators show 
stable expression filling the neuron’s cytosol and are excluded from the 
nucleus (Figure 13C). 
To compare the response properties, neurons were stimulated with high 
potassium (50 mM KCl) that promoted depolarization of the membrane and 
subsequent opening of voltage gated calcium channels. 
Repeated stimuli of transfected hippocampal neurons led to stable signals 
obtained with both indicators. TN-XL showed about twice the signals 
compared to TN-L15 (Figure 13A and Figure 13B respectively). Fluorescent 
responses obtained from the individual cells rely on the FRET-mechanism as 
it can be seen in the individual FRET channels (Figure 13A and Figure 13B, 
lower traces). Upon stimulation with KCl one can observe a decrease in the 
donor/CFP channel (485/35 nm) with a simultaneously increase in the 
acceptor/Citrine cp174 channel (535/25 nm). Enhanced signals produced by 
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TN-XL are in line with the increased ΔR/Rmax that can be seen in the purified 
indicator proteins (Figure 8 and Figure 10). 
 
 
Figure 13: Performance of TN-XL and TN-L15 in primary hippocampal neurons. 
(A) Traces obtained from a rat hippocampal neuron transfected with TN-XL. Upper trace shows the 
changes of the YFP/CFP ratio depicted in [%]. The cell was repeatedly stimulated by high potassium (50 
mM) followed by washout (asterisks). Lower trace shows the corresponding changes in intensities of the 
YFP (535/25 nm) and the CFP (485/35 nm) channel. Time axes for ratio and intensities have the same 
time scale. (B) Responses of a primary hippocampal neuron transfected with TN-L15 treated like A. (C) 
Primary hippocampal neuron expressing TN-XL. The image shows the Citrine cp174 emission at 535/25 
nm upon excitation at 440/20 nm. Scale bar 10 μm. 
 
 
4.2. Red-shifted variants of TN-XL 
 
Shifting the emission spectra of genetically-encoded calcium indicators is a 
prerequisite for multicolor and deeper in vivo imaging. In the following I 
present the results of exchanging donor and acceptor proteins in TN-XL with 
longer emitting species of fluorescent proteins. 
 
During this thesis a variety of new red-shifted proteins were developed (29, 
30). To yield a red-shifted variant of our genetically-encoded calcium sensor, I 
replaced the donor (CFP) with Citrine and the acceptor (Citrine cp174) with 
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mOrange and tdTomato respectively. Figure 14 shows spectra of both purified 
indicator proteins before and after calcium saturation. 
TN-XL Citrine_mOrange showed a ΔR/R from zero calcium to calcium 
saturation of 15 % (peak values: 562 nm/527 nm) whereas TN-XL 
Citrine_Tomato displayed a ΔR/R value of 50 % (peak values: 581 nm /527 
nm). Excitation took place at 495 nm (for Citrine) and the emission spectra 
were taken between 505 nm and 650 nm. Both indicators displayed a calcium-
induced FRET although their signal strength was not comparable to the 
CFP/Citrine cp174 variant of TN-XL (ΔR/R = 400 % from zero calcium to 
calcium saturation). 
 
 
Figure 14: Fluorescent emission spectra of red-shifted TN-XL variants. 
Donor and acceptor replacement yielded indicators TN-XL Citrine_mOrange and TN-XL Citrine_Tomato. 
Both indicators display only moderate FRET signals upon calcium saturation. For both constructs 
excitation took place at 495 nm. Emission spectra were taken from 505 nm to 650 nm.  
 
To illustrate the red-shift, spectra of TN-XL and TN-XL Citrine_Tomato are 
drawn into the same plot (Figure 15A). The gain of such a red-shifted indicator 
would be 52 nm the difference between Citrine cp174 emission peak (527 nm) 
and CFP emission peak (475 nm). Figure 15B displays the fluorescence 
spectra of the individually purified fluorescent proteins (Citrine and tdTomato).  
Note that the excitation spectra of Citrine and tdTomato overlap to a high 
degree which hardly allows for excitation of the donor without simultaneous 
direct excitation of the acceptor and therefore a high degree of fluorescence in 
the acceptor channel that is not elicit by the resonance energy transfer. 
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Figure 15: Comparison of the red-shift approach to CFP/YFP FRET indicators. 
(A) Fluorescence emission spectra of calcium free and calcium saturated TN-XL and TN-XL 
Citrine_Tomato (RS_TN-XL) are plotted in the same graph to illustrate the gain in wavelength shift. 
Such a shift would be 52 nm to the ‘red-side’. All spectra are normalized to their isosbestic point (514 
nm for CFP/YFP and 565 nm for YFP/Tomato). The huge discrepancy in signal production after calcium 
saturation can be easily seen between the two donor/acceptor variants. (B) Normalized fluorescence 
excitation and emission spectra of Citrine and tdTomato.  
 
 
4.3. Point mutating the csTnC backbone of TN-XL to lower the 
Kd for calcium 
 
This paragraph describes the results obtained by point mutating the csTnC 
backbone of TN-XL. Point mutations were introduced to the calcium binding 
moiety in order to reduce the Kd value of TN-XL for calcium and to enhance 
signal strength this troponin C-based GECI. These point mutations are not 
applied to positions inside the calcium binding loop of the EF-hand domains. 
This shows that altering the Kd-value of a calcium binding protein can also be 
achieved by changing amino acids that are not directly involved in calcium 
coordination. 
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4.3.1. Tuning the troponin C backbone of TN-XL by introducing 
point mutations in the N-terminal part of csTnC 
 
Compared to TN-L15, the magnesium insensitive calcium biosensor TN-XL 
displays a higher Kd value for calcium (0.7 μM vs. 2.2 μM). To increase 
calcium affinity in TN-XL, I applied different point mutations in the unmutated 
N-terminal part that is known to be less calcium sensitive than the C-terminal 
lobe. For that purpose I tried to exchange hydrophobic residues in the N-
terminal lobe with more polar groups. This should promote the transition of the 
apo (calcium free state) to the calcium bound state due to increased solvent 
accessibility and therefore the reduction of energy that is needed to drive this 
transition (65, 66). Point mutations were inserted at position Phe22, Val45, 
Met46, Leu49, Val65, Met82 and Met86. Figure 16 gives a summary of the 
mutated and purified sensor proteins with respect to their calcium dissociation 
constants. 
 
Figure 16: Substitution of single hydrophobic residues in the N-terminal lobe of csTnC 
in TN-XL. 
Normalized calcium titration curves (A) and extracted Kd values (B) of different amino acid substitutions 
in the N-terminal lobe of the csTnC backbone in TN-XL. Residues that were used to mutate refer to as 
F22, V45, M46, L49, V65, M82 and M86. Except for TN-XL (average of four different titrations of four 
purified proteins) data represents one titration. 
 
As it can be seen in Figure 16 only the mutations V65G and M86Q led to a 
decrease of the Kd value although both mutations provided only small effects 
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on the dissociation constant (2.0 μM for V65G, 1.7 μM for M86Q compared to 
2.2 μM in the unmutated TN-XL). 
 
 
4.3.2. Effect of the mutation I130T in csTnC’s C-terminal part of TN-
XL  
 
As mentioned before the C-terminal part of troponin C displays a higher 
calcium affinity than the N-terminal lobe. Dissociation constant of a given EF-
hand not only depends on the chelating residues that bind the calcium inside 
the loop region. It has been recognized that particular amino acid residues 
outside the binding-loop can have a strong effect on calcium chelation like 
position 130 in csTnC. In wild type csTnC this position is occupied by an 
isoleucine. One particular study by Trigo-Gonzalez and colleagues showed 
that replacement of this side chain with threonine leads to a stabilization of the 
two C-terminal EF-hands and to an increase in calcium affinity for that EF-
hand domain (67). I introduced this particular amino acid substitution to our 
mutated csTnC backbone of TN-XL with the aim of lowering the Kd value for 
calcium of TN-XL. Figure 17A shows the normalized titration curves of TN-XL 
and TN-XL I130T. Spectra show a shift of TN-XL I130T to the left side 
representing a lower Kd value for TN-XL I130T (1.6 μM) compared to TN-XL 
(2.2 μM).  
To further increase calcium affinity of our biosensor I introduced the M86Q 
mutation to yield the double mutant TN-XL M86Q I130T. Since the M86Q 
substitution worked well in TN-XL the intention was to further lower the Kd 
value with the combined substitution. As it can be seen in Figure 17A, this 
approach indeed led to a decreased Kd value of 740 nM for TN-XL M86Q 
I130T. For a more profound comparison of TN-XL, TN-XL M86Q, TN-XL 
I130T and TN-XL M86Q I130T the actual ΔR/R values in [%] are depicted in 
Figure 17B. For each indicator the signals are plot against free calcium values 
from zero to 1.35 μM (in presence of 1 mM Mg2+), a range that might best 
reflect the cytosolic Δ[Ca2+]i of a stimulated cell. 
58 
Results 
 
Figure 17: Effect of the I130T mutation in the C-terminal part of csTnC in TN-XL. 
(A) Comparison of normalized calcium titration curves obtained from TN-XL, TN-XL M86Q, TN-XL I130T 
and the double mutant TN-XL M86Q I130T. A dose response fit to the individual curves yielded Kd 
values of 1.7 μM (TN-XL M86Q), 1.6 μM (TN-XL I130T), 0.74 μM (TN-XL M86Q I130T) and 2.2 μM (TN-
XL). (B) Signals obtained with the different indicators as ΔR/R in [%] according to the calcium regime 
from zero to 1.35 μM free Ca2+. Signals obtained from TN-XL I130T and TN-XL M86Q I130T show 
similar values and exceed the values obtained from TN-XL and TN-XL M86Q. Except for TN-XL 
(average of four different titrations of four purified proteins) and TN-XL I130T (average of three different 
titrations of two purified proteins) data represents one titration. 
 
In contrast to the pure Kd values it becomes clear that lowering the Kd value 
not necessarily displays an improvement according to signal strength as the 
ΔR/Rmax also varies between the different sensors. In this case one can 
observe an almost equal enhancement of signal obtained with TN-XL I130T 
and the double mutated TN-XL M86Q I130T according to TN-XL. This makes 
the significant difference of the Kd value of these two sensors negligible. In 
other words the single mutation I130T in TN-XL is sufficient to increase the 
signal strength of this biosensor. 
 
 
4.4. Development of TN-XXL, a genetically-encoded calcium 
indicator with enhanced signal strength 
 
In the following section I will introduce the ‘doubling strategy’ that led to a 
genetically-encoded calcium indicator with enhanced signal strength. The 
strategy was to double a high affinity EF-hand domain consisting of two 
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calcium binding EF-hands. The strategy was applied to the C-terminal part of 
csTnC carrying different point mutations. 
 
 
4.4.1. Doubling the csTnC’s C-terminal part of TN-XL I130T 
 
Instead of introducing point mutations to enhance signal strength I tried to 
perform a more profound rearrangement of the csTnC backbone. For that 
purpose a doubling of the high affinity C-terminal part was considered to be 
suitable of lowering the Kd-value by simultaneously preserve the high ΔR/Rmax 
obtained with TN-XL.  
I decided to double the C-terminus with different starting and ending points. 
As one starting point I chose serine94 (S94, S) and, additionally, added two 
amino acids in front of serine94 namely threonine and aspartic acid (TDS) that 
are found to precede the according serine positioned in wild type CaM. As 
ending points methionine158 (M158, M) and glutamine162 (Q162, Q) were 
chosen. The C-terminal domain of csTnC was shortened by four amino acids 
(when stop is at Met158) because the crystal structure (pdb entry 1TOP) 
shows the end of the exiting helix of EF-hand IV at this position. Figure 18A 
displays the graph of normalized titration curves obtained from the 
investigated doublings. All doublings were performed on the mutated C-
terminal part of csTnC as it was used for TN-XL I130T. Names of the 
biosensors reflect the overall building scheme. For example S-Q_S-Q can be 
described as follows: 
 
CFP - Ser94 - Glu162 - Gly Thr - Ser94 - Glu162 - Citrine cp174 
 
The domains are linked together by a KpnI restriction site that encodes for 
glycine/threonine (underlined). In case of starting with TDS as second part the 
threonine was used from the restriction site to avoid doubling of this particular 
amino acid residue. 
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Figure 18: Doubling the C-terminal part of csTnC in TN-XL I130T. 
(A) Normalized titration curves obtained from different C-terminal doublings of the C-terminal lobe of 
csTnC as used in TN-XL I130T. For Kd values see Figure 19. (B) ΔR/R values in [%] acquired from the 
individual C-terminal doublings according to zero up to 1.35 μM free Ca2+. None of the doublings display 
a significant enhancement in strength compared to the TN-XL I130T variant (red curve). Note that of all 
doublings the S-Q_S-Q variant shows the highest ΔR/R values (blue curve). Except for TN-XL (average 
of four different titrations of four purified proteins) and TN-XL I130T (average of three different titrations 
of two purified proteins) data represents one titration. 
 
With respect to the calcium regime from zero to 1.35 μM from all tested 
doublings the S-Q_S-Q variant displayed the best improvement according to 
TN-XL (Figure 18B). Unfortunately none of the doublings provided a higher 
actual signal than TN-XL I130T according to small calcium changes (65 nM to 
800 nM).  
 
 
Figure 19: Kd and ΔR/R values obtained from the C-terminal doubling variants of TN-XL 
I130T. 
Calcium dissociation constants were extracted by a dose response fit of the curves depicted in Figure 
18A. ΔR/R represents the ratio change obtained from the variants at 39.8 μM free Ca2+. Except for TN-
XL (average of four different titrations of four purified proteins) and TN-XL I130T (average of three 
different titrations of two purified proteins) data represents one titration. 
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Compared to TN-XL, S-Q_S-Q displayed no significant enhancement in ΔR/R 
values up to 100 nM free Ca2+. In contrast, a significant improvement in signal 
strength can be observed from 225 nM up to 1.35 μM (on average a 1.9 fold 
enhancement). Figure 19 gives a summary of all Kd values extracted from the 
individual doublings and the ΔR/Rmax value obtained at 39.8 μM free calcium 
(in presence of 1 mM magnesium). 
 
 
4.4.2. Doubling the csTnC’s C-terminal part of TN-L15 N108D 
D110N I130T Citrine cp174 
 
Among all tested variants of TN-XL introduction of the single mutation I130T 
alone led to the most dramatic improvement of signal strength. As mentioned 
before disruption of the Z-acid pairs of EF-hand III and IV not only removed 
magnesium-induced FRET signals in TN-XL but also lowered the Kd value for 
calcium. As shown in Figure 10, the single mutations of EF-hand III and EF-
hand IV alone showed a significant disruption in magnesium binding. Both 
indicators display lower Kd values than TN-XL as it can be seen in Figure 
20A. Compared to TN-L15 N144D D146N Citrine cp174 in which EF-hand IV 
is mutated, TN-L15 N108D D110N Citrine cp174 exhibits a much more 
diminished magnesium-induced FRET signal (Figure 10). Interestingly, this 
biosensor showed the smaller Kd value of both single mutated EF-hand 
sensors (1.3 μM vs. 1.6 μM). A closer look at the actual ΔR/R values gives 
rise to a signal enhancement of TN-L15 N108D D110N Citrine cp174 that 
reaches and eventually exceeds the TN-XL I130T values (Figure 20B). 
As a next step I introduced the mutation I130T in the TN-L15 N108D D110N 
Citrine cp174 backbone to see if this mutation has the same effect on signal 
strength as in TN-XL. Again a dramatic increase can be observed especially 
in the low calcium regime from 65 nM up to 600 nM. Only above this value the 
signals were similar or smaller than omitting the I130T mutation. With the 
knowledge about the C-terminal doubling of TN-XL I130T, I also tried to apply 
this strategy to the csTnC’s C-terminal part from TN-L15 N108D D110N I130T 
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Citrine cp174. For that purpose I again used the start and end points serine94 
and glutamine162. The resulting building scheme is depicted in Figure 21.  
 
 
Figure 20: Characteristics of TN-L15 Citrine cp174 variants with single mutated EF-
hand loops. 
(A) Comparison of normalized calcium titration curves of different sensors with mutated EF-hand loops. 
Among those the double disrupted Z-acid pair variants are TN-XL and TN-XL I130T. Single mutated EF-
hand sensors are TN-L15 N108D D110N Citrine cp174, TN-L15 N108D D110N I130T Citrine cp174 (Z-
acid pair in EF loop III disrupted) and TN-L15 N144D D146N Citrine cp174 (Z-acid pair in EF loop IV 
disrupted). TN-L15 N108D D110N I130T Citrine cp174 shows an unusual titration curve that roughly 
displays biphasic characteristics (see also Figure 42). (B) Comparison of signal strength obtained from 
the variants in A according to the calcium concentration from zero to 1.35 μM. Note the significant 
enhancement of the signals obtained from TN-L15 N108D D110N I130T Citrine cp174 in the low 
calcium regime of 65 nM to 600 nM. Except for TN-XL (average of four different titrations of four purified 
proteins) and TN-XL I130T (average of three different titrations of two purified proteins) data represents 
one titration. 
 
I determined the calcium dissociation constant of this indicator by titration 
which yielded a Kd value of 800 nM (Figure 22A). This reflects a tremendous 
lowering of the dissociation constant in contrast to TN-XL (2.2 μM) by almost 
retaining the ΔR/Rmax (230 % vs. 250 %, in presence of 1 mM Mg2+). 
Therefore this indicator was named TN-XXL. Improvement of TN-XXL is best 
displayed by comparison of the actual signals produced by defined calcium 
values. As depicted in Figure 22B TN-XXL performs superior to all the other 
promising indicators tested so far. Comparing the ΔR/R values elicited by the 
different TnC-based indicators TN-L15, TN-L15 N108D D110N I130T Citrine 
cp174, TN-XL and TN-XXL one can observe a dramatic increase in signal 
strength obtained with TN-XXL.  
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Figure 21: Schematic drawing of the strategy used to develop TN-XXL. 
Upper row shows positions of interest according to the wt_csTnC (wild type chicken skeletal troponin C) 
as it is used in TN-L15. These positions are serine94 (start), asparagine108, aspartic acid110, 
isoleucine130 and glutamine162 (end). Note that each of these amino acids resides in the C-terminal 
part of troponin C. The individual EF-hands are depicted in roman numerals. Blue and yellow lines in 
front and behind the schematic of TnC resemble the fusion of CFP and Citrine cp174 respectively. The 
whole C-terminal fragment between serine94 and glutamine162 was doubled and sandwiched between 
CFP and Citrine cp174. As linker between the fragments a KpnI site was used that encodes for the 
amino acids GlyThr (green). 
 
 
 
Figure 22: Comparison of selected troponin C-based GECIs. 
(A) Calcium titration curves obtained from TN-L15, TN-L15 N108D D110N I130T Citrine cp174, TN-XL 
and TN-XXL. Note that TN-L15 and TN-XXL almost display the same Kd value (710 nM vs. 800 nM) but 
with a different ΔR/Rmax (80 % vs. 230 %). (B) Actual signals in [%] elicited by the different variants in 
the low calcium regime. Note that the signal enhancement of TN-L15 N108D D110N I130T, as it can 
also be seen in Figure 20, is preserved in TN-XXL and stays above all other troponin C-based calcium 
indicators investigated so far. On average one finds a 2.4 fold enhancement in signal strength of TN-
XXL according to TN-L15. Except for TN-L15 N108D D110N I130T Citrine cp174 (one titration) data 
represents the average of four measurements from four different purified proteins. 
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The values even exceeded those of TN-L15 N108D D110N I130T Citrine 
cp174 which displayed the highest reached so far. 
Apart from the enhancement seen with TN-L15 N108D D110N I130T Citrine 
cp174, TN-XXL preserved the signals in the low calcium regime of 65 nM to 
600 nM and did not show a decline above these values. When compared to 
TN-L15, TN-XXL showed a 2.4 fold enhancement in signal strength according 
to free calcium values of 65 nM to 1.35 μM. 
 
 
4.5. Comparison of TN-L15, TN-XL and TN-XXL with respect to 
decay time constant τ 
 
As mentioned before actual signal strength is not the only parameter that is of 
importance when describing a calcium indicator as, in addition, how fast a 
given calcium signal can be transduced into a FRET signal must also be 
considered. For that purpose I performed stopped-flow measurements of the 
purified indicator proteins to determine the decay time constant of selected 
TnC-based indicators. Again purified proteins were rapidly mixed with 10 mM 
BAPTA to measure the decay time constant. This time constant reflects the 
Koff rate since the buffer system exceeds the indicator concentration and the 
Kd value for BAPTA is much smaller than the dissociation constants of the 
indicators. Having measured the Kd and Koff values, one can extract the Kon 
rates by the relation Kd = Koff/Kon.  
Figure 23 shows the 527 nm/475 nm ratio decay of the individual troponin C-
based calcium indicators that has been calculated from the measurements of 
three independent (three purifications) experiments per indicator. Single and 
double exponential fits were applied to the data obtained from the different 
indicators. As seen in Figure 23, all curves can be best described by a double 
exponential fit that might reflect uneven calcium binding properties of the 
different calcium binding sites in each indicator. Of all troponin C-based 
indicators TN-XL possess the fastest decay time constant and hence Koff. It is 
followed by TN-XXL that in turn shows a smaller τ than TN-L15.  
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Figure 23: Comparison of decay time constants obtained from TnC-based GECIs. 
Stopped-flow measurements for determination of the decay time constant of (A) TN-L15, (B) TN-XXL 
and (C) TN-XL. Data represent the average 527 nm/475 nm decay of three measurements. In each 
experiment the ratio decay was calculated by averaging the CFP rise and YFP decay from at least nine 
runs. Data obtained from the stopped-flow measurements were fitted by a single (left column, red 
traces) or double (right column, red traces) exponential function. 
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Traces of TN-L15 are much noisier reflecting the overall reduced fractional 
fluorescence change compared to those that can be obtained with TN-XL and 
TN-XXL. It is not surprising that the fastest decay time constant is achieved 
with TN-XL since this indicator shows the highest Kd value of all three 
sensors. A higher Kd value should yield a higher Koff value and therefore a 
faster decay time constant. On the other hand TN-L15 and TN-XXL displayed 
almost the same Kd value but have different decay time constants. This in 
turn supposes a different Kon value for these two indicators. 
 
 
Figure 24: Comparison of the parameters obtained from TnC-based GECIs. 
 
Figure 24 gives a summary of all measured and calculated parameters of the 
TnC-based GECIs TN-L15, TN-XL and TN-XXL 
 
 
4.6. Performance of TN-XXL in cell culture 
 
The upcoming paragraph depicts calcium imaging with TN-XXL in cell culture. 
Calcium imaging was performed in primary hippocampal neurons and 
HEK293 cells from which stable calcium signals were recorded. 
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4.6.1. Detection of calcium signals in primary hippocampal 
neurons with TN-XXL 
 
As a first test of TN-XXL dissociated primary hippocampal cell cultures were 
transfected. It is known that these neurons become spontaneously active after 
two weeks in culture. This activity can be reliably detected with TN-XXL as is 
shown in Figure 25. Primary hippocampal neuron displayed oscillations in its 
cytosolic calcium level within a timescale of minutes that are reflected by a 
change in the ΔR/R values (red curve). Neurons were imaged at a frame rate 
of 0.5 Hz. Intensity traces of the donor and acceptor are plotted with colors 
according to their emission (CFP, blue line and Citrine cp174, yellow line). 
 
 
Figure 25: Activity of a primary hippocampal cell reported by TN-XXL. 
A single primary hippocampal neuron was recorded after two weeks in cell culture. Red trace represents 
the ΔR/R in [%] obtained from that cell within a recording time of 25 minutes. Each peak corresponds to 
a decrease in the CFP channel and an increase in the YFP (Citrine cp174) channel depicted as ΔF/F in 
[%] in the upper traces resembling the FRET-mechanism of TN-XXL. Acquisition was at 0.5 Hz. 
Excitation was at 440/20 nm and the individual channels were recorded at 535/25 nm (for Citrine cp174) 
and 485/35 nm (for CFP). 
 
To test if the signals are promoted by neuronal activity, 1 μM TTX was applied 
to the cultures to inhibit voltage gated sodium channels and thereby the 
initiation of action potentials. Figure 26A shows the response of a neuron 
before and after treatment with TTX. One can observe calcium transients that 
are prevented during treatment with 1 μM TTX. After washout of the drug, the 
neuron starts again to produce calcium oscillations. Figure 26B shows a 
blowup of the experiment in Figure 26A (black box). Signals are produced by 
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the FRET-mechanism as can be seen by reciprocal behavior of the individual 
wavelengths corresponding to the donor (CFP, blue line) and acceptor protein 
(Citrine cp174, yellow line).  
 
 
Figure 26: Inhibition of the calcium signals produced by primary hippocampal neurons 
with TTX. 
(A) Calcium signals in primary hippocampal neurons are inhibited by TTX indicating a dependency on 
active neuronal processes. After applying 1 μM of TTX signals are diminished and are re-initiated after 
removal of the drug by washing. (B) Amplification of data presented in A (black box) shows the response 
of CFP (blue) and Citrine cp174 (yellow). Imaging conditions were the same as in Figure 25. 
 
 
4.6.2. Imaging calcium oscillatons in HEK293 cells 
 
In contrast to primary hippocampal neurons, HEK293 cells are not 
spontaneously active. In these cells, calcium oscillations can be induced by 
stimulating their muscarinic receptors via the agonist Carbachol. After 
transfecting HEK293 with TN-XXL 1 mM Carbachol to the cell culture was 
added. As it can be seen in Figure 27 stimulation of the muscarinic receptor 
system indeed led to calcium oscillations that were reported by the calcium 
indicator TN-XXL (red trace). As the calcium signals measured in the primary 
hippocampal neurons, signals obtained from HEK293 cells are based on the 
FRET-mechanism, as it can be seen in the individual traces of the donor 
(CFP, blue trace) and acceptor emission respectively (Citrine cp174, yellow 
trace)  
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Figure 27: Eliciting calcium oscillations in HEK293 cells. 
(A) A HEK293 cell expressing the genetically-encoded calcium indicator TN-XXL shows calcium 
oscillations after stimulation with 1 mM Carbachol. Red trace shows the ΔR/R as it can be calculated 
from the individual wavelengths depicted in blue (CFP) and yellow (Citrine cp174). Imaging conditions 
were the same as in Figure 25. (B) Fluorescence image of Citrine cp174 (535/25 nm) elicited upon 
excitation at 440/20 nm of HEK293 cells expressing TN-XXL. Scale bar, 10 μm. 
 
For a profound in vivo comparison of TN-L15, TN-XL and TN-XXL the reader 
is referred to the ‘Discussion – In vivo comparison of troponin C-based GECIs 
at the Drosophila NMJ’ chapter. There, all troponin C-based genetically-
encoded calcium indicators were compared under the same in vivo conditions 
using the Drosophila neuromuscular junction as a reliable in vivo test system. 
 
 
4.7. Applying different strategies to improve the troponin C-
based GECI TN-XXL 
 
The improvement that has been achieved with the development of TN-XXL so 
far mostly relied on a structural re-arrangement of the troponin C backbone of 
the calcium indicator. Three additional strategies were performed to further 
modulate the response properties of TN-XXL in order to enhance the signal 
strength. First the ‘doubling strategy’ was expanded to TnC’s from different 
animals, second the amount of calcium binding sites in TN-XXL was reduced 
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and third, specific positions inside the calcium binding loops of EF III and EF 
IV were target of point mutations to directly lower the Kd value for calcium of 
TN-XXL. 
 
 
4.7.1. Expanding the C-terminal doubling strategy to variants of 
troponin C from different species 
 
In order to further increase the signal strength of TN-XXL I tried to apply the 
C-terminal doubling strategy to variants of troponin C from different species. 
For that purpose I chose chicken skeletal TnC (C), mouse skeletal TnC (M) 
and zebrafish skeletal TnC (Z). In all TnC’s I introduced mutations that led to 
the disruption of the Z-acid pair in the according EF-hand III. For mouse and 
zebrafish TnC these mutations refer to as N105D and D107N. The 
corresponding I130T mutation of csTnC was omitted since mouse and 
zebrafish TnC already posses a threonine or serine at that position (‘127’). It 
has been shown that there is no difference in the effect of calcium binding 
whether this position is occupied by a threonine or serine (67). Figure 28 
shows an alignment of the C-terminus from the different wild type troponin C 
variants  
 
 
Figure 28: Amino acid alignment of the C-terminal parts of wild type chicken skeletal, 
mouse skeletal and zebrafish skeletal troponin C. 
Red and green boxes highlight the calcium binding loops of EF-hand III and IV respectively. Alignment 
was performed using the TCoffee multiple sequence alignment tool. 
 
All C-terminal lobes display a high similarity although there is variation in the 
region between the two calcium binding loops (red and green). For the 
doubling C-terminal parts were used as follows: csTnC (S94-Q162), zTnC 
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(S91-Q159) and mTnC (S91-Q159). All nine permutations were cloned and 
calcium titration was performed to determine the calcium dissociation constant 
and to obtain the ΔR/R values at calcium concentrations from zero to 1.35 
μM. Figure 29A gives a summary of the normalized titration curves that were 
used to determine the Kd value of all doublings. 
 
 
Figure 29: Titration curves of nine different indicators based on the C-terminal 
doubling of troponin C from different animals. 
(A) Titration curves of nine different indicators based on doubling of the C-terminal domain of troponin C 
from different animals. To obtain the calcium sensors all possible permutations of csTnC (chicken, C), 
mTnC (mouse, M) and zTnC (zebrafish, Z) were created (S94-Q162 for csTnC and S91-Q159 for 
m/zTnC). As reference TN-XXL is plotted in black (mean of four titrations, refers to as TN-CC since it 
resembles the doubling of csTnC). All other curves represent individual titrations and are indexed 
according to their architecture, e.g. in TN-CM the csTnC part preceeds the mTnC part in the artificial 
construct. (B) The graph shows a blow up of signals in [%] obtained at free calcium values from zero to 
1.35 μM. None of the eight constructs significantly exceeds the signal strength obtained with TN-XXL. 
Only TN-ZC and TN-CM roughly display the same signal properties as TN-XXL. Except for TN-XXL (four 
titrations of four purified proteins) data represent one titration. 
 
Different indicators are named according to their building scheme meaning 
which parts of the different C-terminal variants are used as building blocks 
between CFP and Citrine cp174. For example in TN-CM the C-terminal part of 
csTnC (C) preceeds the C-terminal part of mTnC (M). All of the doublings 
yielded indicators that display a calcium dependent FRET change. As it can 
be seen in Figure 29B none of the doublings significantly exceed the actual 
ΔR/R values of TN-XXL although TN-CM and TN-ZC roughly displays the 
same signal strength.  
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Interestingly, all indicators that display the highest signals of all permutations 
posses at least one chicken skeletal troponin C part (two parts in TN-XXL, one 
part in TN-CM and TN-ZC). Figure 30 summarizes the calcium dissociation 
constants and the ΔR/Rmax values of all nine variants. Among these 
permutations TN-ZC displays the lowest Kd value of all indicators (with four 
EF-hands) mentioned so far in this thesis (530 nM). 
 
 
Figure 30: Kd and ΔR/R values obtained from the C-terminal doubling of troponin C 
from different species. 
(A) Calcium dissociation constants were extracted by a dose response fit of the curves depicted in 
Figure 29A. ΔR/R represents the ratio change obtained from the variants at 39.8 μM free Ca2+. Except 
for TN-XXL (average of four different titrations of four purified proteins) data represents one titration. 
 
 
4.7.2. Reducing the calcium binding site in TN-XXL to one C-
terminal domain 
 
One major concern using genetically-encoded calcium indicators is a possible 
buffering effect due to overexpression of a protein that is capable to bind 
calcium in the physiological relevant range. Additionally most of the GECIs 
have more than on calcium binding site meaning a possible stoichiometry of 
more than one bound calcium ion per molecule of indicator (usually 4 mol 
calcium per mol indicator). In order to prevent a calcium buffering effect I tried 
to reduce the overall amount of calcium binding sites in our troponin C-based 
GECIs. For that reason I used a single C-terminal domain (S94-Q162) of the 
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mutated csTnC (N108D D110N I130T) and sandwiched this part between the 
CFP and Citrine cp174 variants of GFP. Due to the reduction of the overall 
amino acid linker between the two FRET chromophores this indicator 
displayed a huge FRET even in the absence of calcium. 
 
 
Figure 31: Reducing the calcium binding moiety of TnC-based GECIs to one EF-hand 
domain. 
(A) Dose response fits to the calcium titration curves obtained from different single EF-hand domain 
indicators. Depicted are two variants that use the mutated C-terminal part from csTnC (including 
mutations N108D D110N I130T). Again the C-terminal domain from serine94 to glutamine162 was used 
and sandwiched between CFP and Citrine cp174 (1xC-term N108D D110N I130T). In case of 1xC-term 
3xP_N108D D110N I130T, three proline residues precede the C-terminal domain. Kd values are 450 nM 
(1xCterm N108D D110N I130T) and 350 nM (1xC-term 3xP_N108D D110N I130T). (B) Signals obtained 
from the different variants depicted in A according to the calcium regime from zero to 1.35 μM. 1xC-term 
3xP_N108D D110N I130T displays roughly the same signal strength up to 600 nM free calcium as TN-
XXL. Except for TN-XXL (average of four different titrations of four purified proteins) data represents one 
titration. 
 
For that reason I tried to tune the FRET by introducing additional prolines that 
are known to promote kinks of a protein backbone in order to change the 
orientation of the two chromophores and therefore change the FRET-
efficiency according to the dependency on the orientation factor (see 
‘Introduction - FRET’). Figure 31 displays calcium titrations performed on two 
calcium sensors with reduced calcium binding sites.  
Although both indicators showed a reduction in the Kd value for calcium 
compared to TN-XXL (450 nM and 350 nM vs. 800 nM), none of them 
significantly exceeded the actual signals obtained with TN-XXL (Figure 31B). 
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4.7.3. Introducing aspartic acid to glutamic acid (DtoE) conversion 
to the -X position of chelating loops III and IV in the TnC backbone 
of TN-XXL 
 
The transition of soluble calcium that is ligated by seven water molecules to a 
coordinated ion inside the loop region of a given EF-hand is achieved by 
replacing the water shell by the chelating residues. For that reason one 
determinant of calcium affinity is the increase of solvent entropy, i.e. the 
amount of exchanged water molecules by the residues. An increase of the 
solvent energy should therefore provide an increase in calcium affinity of a 
calcium binding domain (47).  
 
 
Figure 32: Schematic drawing of the aspartic acid to glutamic acid substitution in -X 
position of chelating loops in EF-hand III and IV of csTnC. 
Upper row shows the chelating loops and involved amino acid residues of the two C-terminal EF-hands 
III and IV of csTnC. Position -X is highlighted. This position coordinates the calcium ion in wt_csTnC via 
a water bridge since it is too far away for direct interaction with the ion. Bottom row shows a theoretical 
picture with substituted residues in the -X position. This substitution refers to as an aspartic acid to 
glutamic acid exchange. Structures were redrawn according to the pdb entry 1TOP using 
DeepView/SwissPdbViewer 3.7. 
 
The calcium ion of EF III and EF IV of csTnC coordinates the ion by seven 
ligands, although one chelating position (-X) binds the ion via a water bridge 
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(68). According to the solvent entropy hypothesis a direct binding of the ion by 
the chelating residue in position -X should increase the affinity of this EF-hand 
due to the additional release of a water molecule from the coordination sphere 
of calcium to the solvent. For that reason I introduced an aspartic acid to 
glutamic acid substitution in both -X positions of EF-hand III and IV of the 
mutated csTnC backbone of TN-L15 N108D D110N I130T Citrine cp174. The 
aim was to elongate the acidic side chain into the loop region, so that direct 
coordination of the calcium ion can occur.  
Figure 32 illustrates a theoretical diagram of the aspartic acid to glutamic acid 
substitution according to the C-terminal calcium binding loops of wild type 
csTnC. As it can be seen in the bottom row, the longer side chain should 
diminish the distance to the calcium ion. In order to further increase calcium 
affinity of TN-XXL, I introduced the DtoE conversion in both EF-hands 
independently and in parallel. This led to the mutated C-terminal parts that 
were used to build all possible permutations.  
 
 
Figure 33: Titration curves obtained from the different aspartic acid to glutamic acid 
substitutions in EF III and IV of TN-XXL. 
(A) Dose response fits to the normalized ΔR/R values elicited by variants with unmutated (DD) and 
double mutated (EE) C-terminal part of csTnC as first block. (B) Dose response fits to the normalized 
ΔR/R values elicited by variants with single mutated (ED and DE) C-terminal part of csTnC as first block. 
Except for TN-XXL (DD/DD, average of four titrations from four independently purified proteins) all data 
represents one titration. 
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Figure 34: Comparison of the actual ΔR/R values in [%] of the aspartic acid to glutamic 
acid substitutions elicited by all permutations. 
(A) Values obtained from the 16 variants sorted according to the first block. (B) Values obtained from the 
16 variants sorted according to the second block. 
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These mutated C-terminal parts referred to as: 
 
csTnC N108D D110N D114E I130T (substitution in EF III, ED) 
csTnC N108D D110N I130T D150E (substitution in EF IV, DE) 
csTnC N108D D110N D114E I130T D150E (substitution in EF III and IV, EE) 
 
As seen from Figure 33 none of the substitutions yielded a significant 
enhancement in calcium affinity. Only the DE/DD (Kd = 790 nM) and ED/DD 
(Kd = 630 nM) showed roughly the same or a slightly lowered Kd value in 
comparison to TN-XXL (Kd = 800 nM). To have a more detailed insight in 
signal strength Figure 34 shows the actual signals in [%] of the variants 
according to the calcium regime of zero to 1.35 μM free Ca2+. Figure 34A 
shows the response of the variants sorted according to the first block meaning 
the first C-terminal part of csTnC that has been used to create the doubling. 
Figure 34B shows the same 16 variants sorted according to the second part of 
the doubling.  
A closer look at the data depicted in Figure 34 reveals a dramatic decrease in 
signal strength of a given indicator that is in line with the amount of aspartic 
acid to glutamic acid substitutions. Interestingly it can be observed that 
introducing the DtoE substitution in the already mutated EF-hand III of csTnC 
did not yield such a dramatic loss in signal strength than introducing the 
glutamic acid in the wild type EF-hand IV. For example DD/ED elicited much 
higher signals than DD/DE as it can be seen in Figure 34A. 
Of all tested variants only DD/ED, DE/DD, ED/DD and ED/ED displayed 
similar signals in the calcium range of zero to 1.35 μM free calcium (Figure 
35) than TN-XXL (DD/DD). Signals obtained from the variant EE/EE, in which 
all -X positions are substituted with glutamic acid, displayed the smallest 
values of all 16 permutations. Except for DE/DD, all of the well working 
variants comprise the DtoE conversion in the mutated EF-hand III of csTnC 
either in the first, the second or both blocks.  
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Figure 35: Selected variants of the aspartic acid to glutamic acid substitution 
compared to TN-XXL. 
 
 
4.8. Comparison of TnC-based with CaM-based GECIs and 
one synthetic calcium indicator (OGB-1) 
 
Different genetically-encoded calcium indicators have been developed in the 
past few years that can be used to measure calcium fluctuations inside living 
cells. In order to integrate our TnC-based calcium indicators I performed 
calcium titrations of different GECIs and one synthetic calcium indicator, 
namely Oregon Green BAPTA (OGB-1). The goal was to compare signal 
strength at the same defined calcium concentrations. For that purpose I 
investigated the genetically-encoded calcium indicators Yellow Cameleon 
3.60 (YC3.60) (57), GCaMP 1.6 (69) and D3cpv (39) and set the resulting 
signals in relation to our TnC-based GECIs. Figure 36 shows the results of the 
titrations and the resulting signals according to the calcium regime of zero to 
1.35 μM. Data for OGB-1 and GCaMP 1.6 reflects ΔF/F values since these 
indicators belong to the family of single wavelength sensors. All the other 
indicators (TN-L15, TN-XL, TN-XXL, YC3.60, D3cpv) belong to the family of 
ratiometric indicators and their signals therefore reflect a ΔR/R. The most 
striking observation that is seen in Figure 36A is the dramatic difference in the 
actual signal that is achieved with the synthetic dye (OGB-1) compared to all 
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GECIs. Figure 36B shows a zoom of the y-axis so that the actual signals of 
each GECI can be more easily seen. None of the genetically-encoded 
sensors displays a comparable sharp rise in the signal as it can be seen with 
OGB-1. 
 
 
Figure 36: Comparison of TnC-based with CaM-based GECIs and OGB-1. 
(A) Signals obtained from the different calcium indicators according to calcium concentrations from zero 
to 1.35 μM. Signals for GCaMP 1.6 and OGB-1 are depicted as ΔF/F values according to their single 
wavelength nature. All signals from the other indicators are indicated as ΔR/R since they exploit the 
FRET-mechanism and therefore reflect ratiometric sensors. (B) A zoom in of the data in A along the y-
axis. Note the huge signal strength that is produced with OGB-1. Except for OGB-1 (average of three 
titrations) the data represent an average of four experiments on four independently purified proteins. 
 
 
 
Figure 37: Comparison of ΔF/F and ΔR/R values from different calcium indicators at 65 
nM free Ca2+. 
Signals obtained from the depicted calcium sensors according to a Δ[Ca2+] of 65 nM. Signals were 
calculated as the fluorescence/ratio change in [%] (± SDM) of peak values from zero to 65 nM calcium. 
For peak values 524 nm (OGB-1), 510 nm (GCaMP 1.6) and 527 nm/475 nm for all FRET-based 
sensors were used. 
80 
Results 
Already at a ΔCa2+ of 17 nM this indicator displays a significant ΔF/F of ~70 
%. Apart from D3cpv none of the GECIs elicit a significant signal for ΔCa2+ = 
17 nM. This is the reason why the smallest free calcium change for titration 
was set to ΔCa2+ = 65 nM. Signals of all investigated calcium indicators that 
were obtained for this value are depicted in Figure 37. 
 
 
4.9. Transgenic animals 
 
Generation of two different transgenic animal models were attempted during 
this research. Transgenic flies were successfully created using the Gal4/UAS-
system (UAS-TN-XXL) that expressed TN-XXL in a pan neuronal manner  
using the elacC155-driver line. In addition I attempted to generate a transgenic 
mouse line that expresses TN-XXL in glial cells using the human GFAP-
promoter, however this was unsuccessful. 
 
4.9.1. Transgenic expression of TN-XXL in Drosophila 
melanogaster 
 
The improvement of troponin C-based calcium indicators that were achieved 
with TN-XXL have been so far just been demonstrated by titration of the 
indicator in the cuvette. To have a more profound idea on how good this 
achievement can be translated in vivo I decided to generate transgenic 
animals. For that purpose the fruit fly Drosophila melanogaster was chosen 
since a reliable in vivo test system exists in that species that had been 
previously used to compare different GECIs in a defined in vivo environment 
(60). For that purpose the larval neuromuscular junction provides a reliable 
test system that allows comparison of the different GECIs with a defined 
stimulation paradigm (and therefore with defined cytosolic Δ[Ca2+]i). I made 
use of the Gal4/UAS-system that allows expression of a transgene of interest 
under the control of a genomic enhancer (70). Creation of a UAS-TN-XXL 
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reporter line was achieved by injection of the construct into fertilized eggs of 
Drosophila melanogaster. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 38: Transgenic expression of TN-XXL in Drosophila melanogaster using the
Gal4/UAS-system. 
Flies are of the genotype elavC155-Gal4/elavC155-Gal4; UAS-TN-XXL/UAS-TN-XXL indicating their
homozygous nature. (A) Light microscopy picture of first, second and third instar larval stage. (B)
Fluorescent picture (YFP-channel) of the larvae depicted in A. (C) and (E) Light microscopy picture of
adult flies of both sexes. In each picture female flies are on the left, male flies on the right side. (D) and
(F) Fluorescent images of the flies depicted in C and E.  
A B  
E F 
C D
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Crossing of these transgenic flies with the driver line elavC155-Gal4 allows the 
expression of the GECI TN-XXL in a pan neuronal manner (71). Figure 38 
shows light and fluorescence images of the double mutant elavC155-
Gal4/elavC155-Gal4; UAS-TN-XXL/UAS-TN-XXL that showed expression of 
TN-XXL in the nervous system of the larval and adult flies. 
These flies were used to compare all three troponin C-based calcium 
indicators TN-L15, TN-XL and TN-XXL in vivo. Hereby the reader is referred 
to section ‘Discussion - In vivo comparison of troponin C-based GECIs at the 
Drosophila NMJ’. 
 
 
4.9.2. Creating transgenic mice with TN-XL and TN-XXL using the 
human GFAP-Promoter 
 
Astrocytes can be regarded as ‘bridging units’ that connect different types of 
cells and structures in their vicinity e.g. neurons and blood vessels (72). They 
are able to promote signaling from neurons to blood vessels to regulate blood 
flow and therefore the energy support of neurons (73) or to modulate neuronal 
transmission via the so-called ‘gliotransmitters’ (e.g. glutamate and ATP) (72). 
Although electrically excitable, astrocytes are not able to produce action 
potentials and therefore their signaling mechanism exclusively relies on 
fluctuations in the cytosolic calcium level (72). 
To investigate calcium signaling in glial cells, I made use of the human GFAP-
promoter successfully used to drive expression of transgenes in this cell type 
(74, 75). Starting DNA for generating transgenic mice was the (human) 
hGFAP_CFP plasmid kindly provided by Frank Kirchchoff. The CFP was 
excised with restriction enzymes AgeI/EcoRI and replaced by TN-XL and TN-
XXL respectively. Figure 39 shows a schematic of the constructs used to 
create transgenic animals. 
As a first test primary hippocampal cell cultures were transfected with the 
plasmid encoding TN-XL under the GFAP promoter. Glial cells were labeled 
and stimulated with ATP leading to an activation of purinergic receptors (76).  
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Figure 39: Schematic of the constructs used to create transgenic mice. 
 
The subsequent calcium rise in the glial cells was detected with TN-XL, 
showing a functional expression of the GECI using the GFAP promoter. 
Figure 40 depicts an example of a glial cell in which TN-XL reports calcium 
signaling.  
After successfully testing the promoter in cell culture, the plasmids containing 
hGFAP_TN-XL/TN-XXL were linearized with DrdI. The 4.7 kb fragment 
containing the promoter, the GECI and a poly-adenylation signal was purified 
and microinjected into pronuclei of fertilized oocytes. From all injections 9 
PCR-positive founders with hGFAP_TN-XL and 30 PCR-positive founders 
with hGFAP_TN-XXL were obtained. After breeding of these 39 founders, 36 
offspring producing lines could be established.  
 
 
Figure 40: Glial calcium signals detected with TN-XL using the hGFAP promoter. 
(A) Responses of a glial cell transfected with hGFAP_TN-XL after stimulation with 400 μM ATP. Red 
trace depicts the Citrine cp174/CFP ratio obtained during the recording session. Blue line (CFP) and 
yellow line (Citrine cp174) correspond to the behavior of the individual chromophores from which an 
increase in FRET could be extracted after the stimulation with ATP. (B) Citrine cp174 image of a glial 
cell transfected with hGFAP_TN-XL. Scale bar, 10 μm. 
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All lines were checked for glial expression of the indicators by extracting the 
brains of PCR-positive offspring (from two animals) or by extracting the brains 
of at least two litters of PCR-positive founders (on average 18 individuals per 
founder). All prepared brains were screened for expression using a 
fluorescence microsope but none of these lines showed expression of one of 
the GECIs in the nervous system. 
 Discussion 
 
 
5.1. Enhancing signal strength in TN-L15 
 
The central aim of my research was to increase the signal strength of the first 
generation of genetically-encoded calcium indicator based on troponin C, 
namely TN-L15. As mentioned before this indicator is suitable to detect 
calcium transients elicited in cell culture (41) and in transgenic animals (60, 
61, 77). The major drawback of TN-L15 however was the lack of this indicator 
to detect small calcium transients especially those elicited by single action 
potentials when expressed in neurons (61).  
In order to overcome this lack of sensitivity I applied various strategies to 
enhance the signal strength of TN-L15. As a first approach I exchanged the 
acceptor protein in TN-L15. The YFP derivative Citrine was used to create 
different circularly permuted variants (58). Among the different variants two 
distinct versions showed similar spectral characteristics as the wild type 
Citrine molecule. These variants referred to as Citrine cp174 and Citrine 
cp158. When replacing the original Citrine with Citrine cp174 in TN-L15 I 
yielded an enhanced signal of the calcium indicator. On the other hand no 
significant enhancement in FRET-efficiency was achieved with the Citrine 
cp158 variant. A circularly permuted variant presumably shows the same 
structure as the wild type protein. The only difference is that the wild type 
termini are linked together (which reflects a closure in the protein backbone) 
and new termini are created at a different site in the protein. When a cp 
variant is fused to a protein the most dramatic effect should be a new 
orientation of the cp variant according to the tagged protein. In case of having 
a FRET sensor this rearrangement should lead to a reorientation of the 
transition diploes of the two fluorescent proteins and so to a change in FRET-
efficiency according to its dependency on the orientation that is reflected by 
the orientation factor κ2. Unfortunately no crystal structure of a FRET-based 
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genetically-encoded calcium indicator is available so far. In that respect it can 
only be speculated that the dramatic increase in FRET-efficiency that can be 
observed with the Citrine cp174 variant is based on a change of the 
orientation. It can not be excluded that introduction of a cp variant to our 
sensors also changes distance of the two chromophores which affects the 
FRET-efficiency in a more dramatic way since latter one depends on the 
inverse of the sixth power of the distance. FRET-efficiency has also been 
improved by use of circular permuted variants in so-called Yellow Cameleons 
a family of genetically-encoded calcium indicators that are based on 
calmodulin (57). Interestingly the authors also used a similar position for the 
circular permutation of the acceptor protein Venus (an YFP derivative). In that 
approach position 173 was used that corresponds to the preceding amino acid 
of the 174 position in the Citrine variant. This shows that usage of cp variants 
of fluorescent proteins represents a robust and general possibility to improve 
efficiency in FRET-based biosensors.  
However, a problem that arose in this approach to improve the indicator was a 
non-restricted increase in FRET-efficiency to calcium. Unfortunately, wild type 
troponin C also binds magnesium that is present in the low millimolar range 
inside a cell (78). Magnesium binding in troponin C is promoted by the high 
affinity C-terminal lobe that is capable of binding both ions (calcium and 
magnesium) (51). As shown in Figure 8 both indicators (TN-L15 and TN-L15 
Citrine cp174) elicited a significant signal with 1 mM magnesium that is 
pronounced in TN-L15 Citrine cp174 showing that magnesium is not only 
bound by troponin C but also elicits a structural change of the binding moiety. 
Given the fact that a GECI faces a similar free magnesium concentration 
inside a cell, this would diminish the overall signal that can be obtained by this 
calcium indicator since the baseline is shifted to an increased FRET which 
reduces the residual FRET response that can be elicited by calcium. This 
magnesium sensitivity of troponin C-based calcium indicators displayed the 
major contribution to the overall reduction in signal strength of troponin C-
based calcium biosensors. The acid pair hypothesis proposes that maximum 
calcium affinity by an EF-hand is elicited with four acidic residues in positions 
1(+X), 5(+Z), 9(-X) and 12(-Z) (79). On the other hand it was demonstrated in 
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synthetic peptides that magnesium binding occurs if the Z-axis is occupied 
with two acidic residues (80). In order to prevent the magnesium binding to 
our sensors I tried to combine the results of the two studies mentioned before 
by disruption of the Z-acid pair, and at the same time maintain the four acidic 
residues in the calcium binding loop of the C-terminal EF-hands III and IV 
present within the csTnC. For disruption of the Z-acid pair only position 5(+Z) 
was considered to be exchanged since the glutamic acid in position 12(-Z) is 
essential for calcium coordination (47). As it can be seen in TN-XL 
magnesium-induced FRET (elicited by 1 mM Mg2+) is almost absent. The 
price that had been paid for the reduced magnesium affinity was an also a 
reduced calcium affinity (0.7 μM for TN-L15 and 2.2 μM for TN-XL). The 
disadvantage becomes clear when actual values of signal strength are 
compared to a calcium regime that can be found in an activated cell (up to 1 
μM). Here one finds an almost complete loss in signal strength of TN-XL 
especially for calcium values up to 350 nM (Figure 22B). Only above this 
calcium value TN-XL produces significant FRET signals. From this data one 
can derive that TN-XL is not a suitable calcium indicator to detect small 
cytosolic calcium changes that are elicited by e.g. a single action potential in 
neurons. Nevertheless one advantage can be found in TN-XL namely the high 
Kd value of TN-XL causes fast off-kinetics. This in turn can be useful when 
investigating calcium transients with higher temporal resolution at sites where 
calcium reaches elevated concentrations. For example, TN-XL would be a 
suitable indicator for studying calcium dynamics at entry sites by attaching to 
a calcium channel. 
 
All the work done so far did not yield the desired improvement of troponin C-
based calcium indicators according to their signal strength. Therefore I tried to 
increase calcium affinity of TN-XL in order to gain enhanced signals especially 
in the low nanomolar calcium regime. A lot of mutagenesis studies have been 
performed on troponin C which reported increased calcium affinity when 
replacing hydrophobic with more polar groups. The idea is to increase the 
solvent accessibility of the csTnC’s N-terminal part and thereby promote the 
structural transition of the apo to the calcium bound state by reducing the 
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energy that is needed for this transition (65, 66). Unfortunately none of the 
introduced substitutions significantly enhanced the FRET signals of TN-XL. 
Especially the mutations F22Q (Kd = 0.99 μM), V45Q (Kd = 0.17 μM), M46Q 
(Kd = 0.88 μM), L49Q (Kd = 0.17 μM), M82Q (Kd = 0.69 μM) and M86Q (Kd = 
2.6 μM) decreased the Kd value of TnC (Kd = 3.2 μM) as shown by Tikunova 
and colleagues (65). At this point one should comment on the different 
determination of Kd values that were used in this study compared to the 
approach used by the other research group. In our case the Kd value reflects 
an apparent Kd value since we use the FRET signal to determine the calcium 
dissociation constant. In other words the Kd values presented in this thesis 
reflect the values at which the FRET signal reaches half maximum according 
to the calcium concentration. Since the FRET-mechanism is a highly non-
linear system (especially due to the dependency on distance) the Kd values 
not necessarily reflect a direct calcium binding to troponin C. One can easily 
imagine that calcium is bound to our indicator and promote a structural 
change of the troponin C backbone that is not converted into a FRET signal 
because the chromophores are too far away to produce a significant energy 
transfer. Only around the Förster radius one can find an almost linear relation 
between distance and FRET-efficiency (Figure 41).  
 
 
Figure 41: Dependency of FRET-efficiency on the distance of two chromophores with a 
Förster radius (R0) of 50 Å. 
Points were calculated using the formula EFRET = R06/(R06 + r6). 
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On the other hand studies on calcium binding are almost exclusively done by 
point mutating a distinct amino acid residue that allows for a more direct 
fluorescent readout of calcium binding. When studying the calcium binding of 
the N-terminal part of troponin C the so called TnCF29W mutant is used that 
produces an intrinsic fluorescent signal due to the incorporation of the 
aromatic tryptophan residue that is more directly changed upon calcium 
binding (65). Therefore it is not necessarily surprising that the same mutations 
applied to the troponin C backbone of our sensor did not produce the same 
decrease in the apparent calcium dissociation constant. Nevertheless our goal 
is not the study of direct calcium binding to troponin C. The interest of this 
research is to generate a genetically-encoded calcium indicator that is suitable 
to pick up small calcium changes that are converted to a fluorescent readout - 
a change in FRET-efficiency between CFP and Citrine. For that reason my 
intention was to compare FRET signals with given free calcium values.  
 
As mentioned in the previous paragraph enhancing signal strength in TN-XL 
by means of single mutations did not lead to success. Thus, a more profound 
way of changing the calcium binding moiety by doubling of the csTnC’s C-
terminal part aimed to increase signal strength. This domain was chosen as it 
is known that the C-terminal lobe of troponin C exhibits a higher calcium 
affinity than the N-terminal counterpart. The doubling was performed since 
most of the calcium binding proteins come along as a multitude of an EF-hand 
domain that exists of two EF-hands. The idea was to preserve the high affinity 
of the C-terminal lobe and in parallel - by doubling this domain - yield enough 
structural rearrangement that can be converted to a high FRET readout. 
Different doublings of the csTnC’s C-terminal part in TN-XL I130T led to 
adequate start- and ending points at which the doubling of the C-terminal lobe 
worked best. These were (according to csTnC) serine94 (as start) and 
glutamine162 (as stop). Most important this doubling variant preserved the 
overall ΔR/Rmax values obtained with TN-XL. At this point the reader should be 
pointed to the effect of a particular single amino acid substitution performed 
on the TN-XL backbone. This mutation corresponds to csTnC I130T. 
Introduction of this mutation to the N-cap residue of the G-helix of chicken 
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skeletal troponin C is thought to stabilize the C-terminal domain and therefore 
enhance their calcium affinity (67). Figure 42 shows the result of the I130T 
mutation in different variants. 
 
 
Figure 42: Effect of the I130T mutation in csTnC -based  calcium indicators. 
(A) Titration curves obtained from TN-XL, TN-XXL and TN-L15 N108D D110N Citrine cp174. Note that 
TN-XXL is built by a doubling of the same C-terminal domain (csTnC N108D D110N I130T). (B) Curves 
obtained from TN-XL I130T, TN-L15 N108D D110N I130T and zTN-L12 N105D D107N (that uses a 
shortened TnC variant from zebrafish as calcium binding moiety. Except for TN-XL and TN-XXL 
(average of four independent measurements performed on four independently purified proteins) the data 
represent a single titration. 
 
As mentioned before, csTnC is composed of two EF-hand domains with 
different calcium affinities. A comparison of the calcium titration curves of TN-
XL (Figure 42A) and TN-XL I130T (Figure 42B) shows an almost perfect 
sigmoidal curve for TN-XL and a slightly pronounced double sigmoidal for TN-
XL I130T. The double sigmoidal curve might reflect different calcium affinities 
of the two EF-hand domains in TN-XL I130T. On the other hand disruption of 
the Z-acid pairs in the loops of EF III and EF IV without the additional I130T 
mutation - as it is been displayed by TN-XL - gives rise to a perfect sigmoidal. 
In other words introduction of the mutations to diminish magnesium binding 
led to equalization of the calcium affinity of the N- and C-terminal EF-hand 
domains. This observation is further promoted when the single EF-hand 
mutant TN-L15 N108D D110N Citrine cp174 and its I130T variant are 
compared. These indicators have only one disrupted Z-acid pair namely in 
EF-hand III. TN-L15 N108D D110N Citrine cp174 shows a slightly double 
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sigmoidal titration curve meaning the restoring of two EF-hand domains with 
different calcium affinities (Figure 42A). This difference is dramatically 
increased by adding the I130T substitution (Figure 42B). The calcium titration 
curve for TN-L15 N108D D110N I130T Citrine cp174 clearly shows double 
sigmoidal characteristics with high responsiveness in the low calcium regime. 
Interestingly, the difference in calcium affinity of the two lobes can also be 
observed in troponin C derived from zebrafish which shows that this is a 
common feature of troponin C. As depicted in Figure 42B, one finds a clear 
double sigmoidal characteristic for zTN-L12 N105D D107N which already 
posses one of the two N-cap residues that stabilizes the C-terminal EF-hand 
domain (serine127, Figure 28). 
Due to the high signals obtained with TN-L15 N108D D110N I130T Citrine 
cp174 that still possesses the low affinity N-terminal lobe, doubling of its C-
terminal part was considered to be fruitful. Taking the part of the mutated 
csTnC (N108D D110N I130T) from amino acid S94 to Q162 and double it 
between CFP and the Citrine cp174 variant led to the calcium sensor TN-XXL 
that exceeded all other indicators’ signals according to concentrations 
between zero and 1.35 μM free Ca2+. A closer look at the titration curve 
obtained with TN-XXL reveals a perfect sigmoidal characteristic. This reflects 
the uniformity that has been achieved by doubling the same (affine) C-
terminal EF-hand domain (Figure 42A). 
 
TN-XXL represents the best performing troponin C-based genetically-encoded 
calcium indicator so far. According to TN-L15 it displays on average a 2.4 fold 
enhancement in signal strength according to calcium concentrations from zero 
to 1.35 μM which was also confirmed by a detailed in vivo comparison at the 
Drosophila NMJ (see 5.3.). Nonetheless TN-XXL surely does not display the 
ultimate GECI not even with respect to signal strength. For that reason two 
different strategies were applied in order to improve TN-XXL. On the one hand 
the doubling strategy was expanded to variants of troponin C from different 
species. On the other hand I tried to enhance calcium affinity by exchanging a 
particular aspartic acid residue in each of the two EF-hands with glutamic acid 
(-X position).  
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Applying the doubling strategy to troponin C from different species did not 
yield an indicator with superior signal strength. Nevertheless this approach 
shows that it is indeed possible to shuffle different C-terminal domains that 
always yielded functional indicators. The C-terminal part can therefore be 
regarded as an autonomous building block. It would be interesting to go 
further down and try to shuffle even smaller parts especially from different 
calcium binding proteins like troponin C, calmodulin or calmodulin related 
proteins. 
A more direct approach to increase signal strength was trying to enhance 
calcium affinity of TN-XXL by direct mutagenesis of the residue that 
contributes to calcium coordination at position -X in the calcium binding loops 
III and IV. As mentioned in the results part the exchange of aspartic acid with 
the longer side chain of glutamic acid should promote a direct co-ordination of 
the calcium ion and therefore an additional release of the last water molecule 
in the coordination sphere of calcium to the solvent. This in turn would 
increase the solvent entropy and thereby display and energetically favored 
state meaning an enhanced affinity of the mutated EF-hand. Unfortunately 
none of the permutations showed any significant increase in signal strength. 
Quite the contrary was observed mostly a significant loss in signal strength. 
The data suggests that the signals decrease by increasing the amount of EF-
hands with a glutamic acid residue in the -X position. An easy explanation for 
this observation would be an unfavorable accumulation of negative charges in 
close vicinity. This might lead to repulsion of the side chains and a 
conformation that does not prefer calcium chelation. Interestingly the 
decrease in signal strength was not as promoted when the -X position in the 
already mutated EF-hand III was occupied by a glutamic acid. This 
observation can only be stated descriptively. It might well be that the wild type 
EF-hand III is able to handle the DtoE conversion per se or that the change in 
position of negative charges in the mutated EF-hand III (N108D D110N) 
stabilizes the introduction of the longer side chain. Alternatively it might be 
that the desired effect of releasing the last water molecule to the solvent only 
takes place when glutamic acid is introduced in EF-hand III and not in EF-
hand IV.  
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5.2. Reducing the calcium binding moiety in troponin C-based 
GECIs to a single EF-hand domain 
 
A major concern by using genetically-encoded calcium indicators is a possible 
effect on the calcium dynamics of a cell that might arise from the additional 
expression of a calcium binding protein. In the case of our troponin C-based 
calcium indicators this could be ‘in the worst case’ a stoichiometry of four 
calcium ions per indicator molecule. This might be a more pronounced effect 
when the indicator is transiently expressed e.g. when using transfection or 
infection (via a virus) techniques. In contrast - by using a transgenic approach 
- one could imagine that the organism has the ability to overcome this 
imbalance in calcium homeostasis by adopting expression of endogenous 
buffers or the calcium turnover rate. This might be the fact since in a 
transgenic animal the organism has to encounter the additional buffer during 
the whole lifetime which sets a longer timeline to overcome a possible 
buffering effect.  
Nevertheless an indicator with lowered calcium binding sites would be an 
interesting tool - also with respect to kinetic characteristics. Therefore I tried to 
lower the overall calcium binding sites in TnC-based GECIs by using only one 
C-terminal domain of the mutated csTnC (N108D D110N I130T). As 
mentioned in the results section replacement of existing four hand moieties 
with shortened calcium binding domains always led to an increased basal 
FRET i.e. in the absence of calcium which can be seen in Figure 43. 
Comparison of the actual ΔR/R values obtained from TN-XXL and 1xC-term 
3xP_N108D D110N I130T shows that both indicators display the same signals 
from 65 nM to 600 nM free Ca2+ (Figure 31B). Since one would expect small 
calcium changes - especially when trying to detect small signals like elicited 
by one or a few action potentials in neurons - usage of the shortened variant 
would be favorable due to the reduced amount of calcium binding sites. At this 
point I would like to stress the difference of the two variants depicted in Figure 
43 that might show the superiority of TN-XXL. As seen in Figure 43B the 
shortened variant displays a much higher basal FRET. In that aspect the basic 
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fluorescence in the CFP channel is much more reduced according to TN-XXL, 
which could lead to serious problems when performing in vivo experiments. 
Our sensors are constructed in a way that upon calcium binding the FRET-
efficiency is enhanced. 
 
 
Figure 43: Comparison of the basal FRET in two TnC-based GECIS with different 
amount of calcium binding sites. 
(A) Representative fluorescence spectrum obtained with TN-XXL that has four calcium binding sites (in 
presence of 1 mM Mg2+). (B) Representative fluorescence spectrum of a shortened variant of troponin 
C-based calcium indicators with just two EF-hands (1xC-term. 3xP_N108D D110N I130T). Note the 
dramatic increase of basal FRET in the shortened variant. 
 
This is reflected by a reduction in the CFP and an increase in the YFP 
channel. Depending on the expression level one can imagine that signals 
obtained from the donor channel of the shortened variant can be low. This in 
turn would cause serious problems in detecting signals since the change in 
fluorescence of the CFP channel could be around background fluorescence. 
As a result signals calculated as ratio changes would be noisier.  
 
 
5.3. In vivo comparison of troponin C-based GECIs at the 
Drosophila NMJ 
 
Comparison of the genetically-encoded calcium indicators were so far 
achieved by measuring the recombinantly expressed purified protein in the 
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cuvette. This allowed a precise comparison of the individual calcium indicators 
in a defined environment. Since the ultimate goal of developing GECIs is in 
vivo calcium imaging one would like to have a precise in vivo test system to 
compare and define the response properties of different calcium indicators. 
For that reason one can make use of the Drosophila neuromuscular junction 
as a test system where stimulus frequency and Δ[Ca2+]i show linear relation 
(60) and (T. Hendel, personal communication). Experiments were performed 
in the third instar larvae of transgenic animals that express the GECI at nerve 
terminals that innervate muscle 6/7 in the abdominal segment 2 or 3 using the 
elavC155 driver line. Stimulation of presynaptic boutons was achieved by 
delivering voltage pulses of 5.5 V to the innervating fiber through a suction 
electrode eliciting one action potential per pulse. Imaging of boutons was 
performed by 2P-microscopy (with 485/40 nm bandpass filter for CFP and 
535/30 nm bandpass filter for Citrine/Citrine cp174) within a period of eight 
seconds at a rate of 8 Hz. Stimulation was applied for two seconds that allow 
reaching a steady state calcium value in the boutons. Response properties of 
the different GECIs were investigated at stimulation frequencies of 10, 20, 40, 
80 and 160 Hz. 
 
The transgenic reporter line UAS-TN-XXL was generated by Alexandra Ihring 
and myself at the MPI of Neurobiology. Generation of the reporter lines UAS-
TN-L15 and UAS-TN-XL were performed by Alexandra Ihring and Maximilian 
Jösch-Krotki. Experiments at the Drosophila NMJ and data analysis were 
completed by Thomas Hendel at the MPI of Neurobiology. Calcium titrations 
of the TnC-based GECIs and OGB-1 were performed by myself.  
 
Figure 44 shows the in vivo responses of TN-L15, TN-XL and TN-XXL 
expressed at the NMJ. 
The results obtained at different stimulus intensities demonstrate a significant 
improvement of TN-XXL, just as has been seen before in the cuvette. For all 
stimulus intensities signals from TN-XXL clearly exceed all the other 
indicators’ responses and especially at low stimulations (10 and 20 Hz) one 
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can find a major improvement in sensitivity when using TN-XXL a as calcium 
reporter. 
 
 
Figure 44: In vivo comparison of troponin C-based GECIs at the Drosophila NMJ. 
(A) 2P-image of presynaptic boutons innervating muscle 6/7 of the Drosophila larval NMJ. Fluorescence 
acquired from the YFP channel. Right: Blow up of the red rectangular. Scale bars: 10 μm (left) and 5 μm 
(right). (B-F) Responses of the three GECIs at different stimulation frequencies ranging from 10 Hz to 
160 Hz. Black bars between 2 s and 4 s indicate the stimulation. (G) ΔR/Rmax values in [%] obtained with 
these indicators plotted against the stimulation frequency. 
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Two observations should be highlighted that correspond to the cuvette data 
shown. Firstly, as seen before in the stopped-flow experiments, TN-XL 
displays the shortest decay time constant of the troponin C-based GECIs and 
this also holds true for the indicator performance at the NMJ. Independent of 
stimulation frequency, TN-XL follows the calcium fluctuation with the most 
precise time resolution that can be obtained with troponin C-based sensors. 
Secondly, TN-XL is almost ‘blind’ to small changes in the cytosolic calcium 
concentration as can be seen for stimulus intensities of 10 or 20 Hz. This is 
also consistent with the data obtained from the calcium titrations. As 
mentioned before stimulation frequency and Δ[Ca2+]i at the Drosophila NMJ 
reveal a linear dependency. Therefore the data in Figure 44G can be 
compared to the ΔR/R values obtained from the calcium titrations that are 
plotted versus the linear calcium concentration. 
 
 
Figure 45: Comparison of actual ΔR/R values in [%] obtained from different csTnC-
based GECIs in two different systems. 
(A) Data obtained from the stimulation of motoneurons innervating the Drosophila NMJ. (B) Data 
obtained from calcium titrations of the purified indicators in the cuvette. 
 
As seen in Figure 45 the overall appearance of the curves obtained from fly 
and the cuvette correspond remarkably well representing a conserved 
response no matter if the indicators are investigated in vitro or cuvette 
measurements. This is an important observation since it allows assessing 
possible improvements of an indicator in the cuvette without the need to 
perform detailed in vivo studies. 
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Nevertheless, as it can also be seen in Figure 45, there exist some 
discrepancies between the in vivo and titration data obtained from the cuvette. 
For example TN-XXL, the indicator seems to saturate at a ΔR/R value of ~200 
% in the cuvette. In contrast, TN-XXL saturates in vivo at a value of ~150 %. 
To explain this inconsistency, it is important to realize that the cuvette data 
represents an actual ΔR/R in [%] calculated from the two peak values of the 
spectra (475 nm for donor and 527 nm for acceptor). In an in vivo experiment 
one uses bandpass filters that broaden the values obtained in both channels. 
Secondly a cell at rest displays a given intracellular calcium level. This has 
also to be considered since any resting calcium will set the calcium indicator 
to a different resting FRET ratio R0 from which the corresponding ΔR/R values 
are calculated. This will also diminish the signal that can be obtained from an 
indicator in vivo. Figure 46 shows the consequences on the actual ΔR/R 
values from calcium titration of TN-XXL if these two parameters are taken into 
account.  
 
 
Figure 46: Effect of mimicking in vivo conditions to the spectra of the calcium titrations 
of purified TN-XXL obtained from cuvette data. 
(A) Drop of signal strength in TN-XXL for different parameters. PtoP reflects peak to peak ratio changes 
in [%] according to 475 nm for CFP and 527 nm for Citrine cp174. AtoA reflects area to area ratio 
changes in [%] when integrating the spectra from 520 - 550 nm for Citrine cp174 and 465 - 505 nm for 
CFP. Depicted are the values calculated at two different resting calcium concentrations (zero and 65 
nM). (B) Loss of signal in [%] when PtoP (zero calcium) values are compared to AtoA (65 nM) values. 
This corresponds to the signal loss when ideal cuvette conditions are compared to in vivo imaging 
conditions. 
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One can observe a decrease in the overall signal strength if in vivo imaging 
conditions are mimicked (65 nM resting calcium, bandpass filters: 485/40 nm 
for CFP and 535/30 nm for YFP as integration limits of the spectra to yield 
new values for each channel). Figure 46B shows the loss in signal strength 
when the peak to peak values and zero calcium are compared to the area to 
area values obtained with 65 nM resting calcium. The initial loss of ~60 % at a 
given free calcium value of 100 nM is due to the overall small signals obtained 
at that calcium concentration and therefore overestimated.  
 
 
Figure 47: Comparison of in vivo mimicked data of calcium titrations to in vivo data 
obtained at the Drosophila NMJ for three TnC-based GECIs. 
Signals acquired from the two systems for (A) TN-L15, (B) TN-XL and (C) TN-XXL. The x-axis depicts 
the deflection in the calcium concentration. For the cuvette data baseline is set to 65 nM to mimic resting 
calcium inside the boutons. Additionally all signals are calculated according to the loss of bandpass 
filters. In vivo data refer to 0, 10, 20, 40, 80 and 160 Hz stimulation that give rise to a deflection in the 
intracellular calcium level of 0, 0.11, 0.22, 0.45, 0.91 and 1.83 μM. 
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Nevertheless, when the ideal cuvette data (peak to peak, zero resting 
calcium) above 100 nM free Ca2+ are compared to the in vivo mimicked data 
(area to area, 65 nM resting calcium), one finds a robust overall 15 - 30 % 
loss in signal strength. Comparing the in vivo mimicked data of the titrations 
with the signals obtained at different stimulation frequencies acquired at the 
fly’s NMJ, the discrepancy in signal strength observed in the two systems 
vanishes. Figure 47 depicts a comparison of the data obtained in the two 
systems. Cuvette data correspond to ΔR/R values in [%] that were calculated 
accounting for the use of bandpass filters and a resting calcium concentration 
of 65 nM. The x-axis depicts the deflection of calcium from this resting value. 
To compare the cuvette data to the in vivo data, an intracellular calcium 
estimation was performed using the synthetic calcium indicator OGB-1. The 
method used here has been described by Maravall and colleagues (81) and 
was performed by Thomas Hendel. A resting calcium concentration of 31 nM 
has been determined in the unstimulated boutons with a deflection of calcium 
(Δ[Ca2+]) of 110 nM (10 Hz), 220 nM (20 Hz), 450 nM (40 Hz), 910 nM (80 Hz) 
and 1.83 μM (160 Hz). Since all TnC-based GECIs diplayed poor or absent 
signals to calcium concentrations from zero to 65 nM in cuvette titrations, fly 
data were aligned with the bandpass filtered data according to 65 nM from 
cuvette measurements which displayed the best estimation for the resting 
state in the boutons. When the corrected data are compared, one finds a good 
agreement of cuvette and in vivo data. For 10, 20 and 160 Hz both systems 
yield the same ΔR/R values for all three indicators. Interestingly data obtained 
from the Drosophila NMJ shows slightly bigger signals for 40 Hz and 80 Hz 
stimulation. Nevertheless, if these considerations are taken into account 
(usage of bandpass filters and a resting calcium concentration), a dramatic 
loss in performance of a GECI may not necessarily be due to folding problems 
or inactivation of the protein-based calcium indicator in in vivo applications. 
Quite the contrary, the loss of signal strength of a calcium indicator can be 
easily explained by the basic conditions that are faced in in vivo calcium 
imaging experiments like the use of bandpass filters and the resting calcium 
state of a cell as it is clearly demonstrated by Figure 47. Especially for high 
affinity calcium indicators the resting calcium concentration can have a 
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dramatic effect on the signal strength that can be obtained in vivo 
applications. When determining the peak ΔF/F values in [%] of OGB-1 in 
cuvette titrations starting from baseline levels of zero, 38 nM and 65 nM free 
calcium, the maximum signal drops from 800 % to below 200 % (Figure 48). 
Since most of the GECIs do not belong to high affinity calcium indicators and 
therefore show only moderate responsiveness to really small absolute calcium 
values (up to 50 - 100 nM), the drawback of having a resting calcium state 
inside a cell does not diminish the signals of GECIs in that way as it would 
affect high affinity synthetic calcium indicators. One exception might be D3cpv 
which already shows a significant signal at 65 nM (46 % ΔR/R). Although 
OGB-1 encounters a dramatic reduction in signal strength when considering a 
resting calcium level, the overall high fractional fluorescence change of this 
synthetic indicator is able to buffer this drawback.  
 
 
Figure 48: Signal strength of OGB-1 obtained at different resting calcium values. 
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5.4. Determination of TN-XXL’s detection threshold in 
organotypic hippocampal slices 
 
As mentioned before the first generation of troponin C-based calcium 
indicators (TN-L15) failed to report cytosolic calcium changes that are elicited 
by single action potentials (61). Therefore we considered the possibility that 
the new generation TN-XXL indicator could close that gap. For that reason we 
expressed TN-XXL by infecting organotypic hippocampal slices with the 
Semliki Forest Virus (SFV) (82, 83). Expression of the GECI is driven by the 
genomic promoter of that particular virus which is able to infect various cell 
types. To elicit different stimuli whole cell patch clamp recordings of 
hippocampal CA1 pyramidal neurons were performed. Cells were held in 
current clamp configuration and action potentials elicited by current pulses of 
0.2 - 0.4 nA for 10 ms injected through the recording electrode. All 
experiments were performed at room temperature. Wide field fluorescence 
imaging was performed with a CCD camera at a rate of 25 Hz. Individual 
channels were recorded using appropriate bandpass filters (480/30 nm for 
CFP and 535/30 nm for YFP) upon excitation with 420/30 nm. 
 
I performed subcloning of TN-XXL into the pSCA vector that has been used to 
create virus particles. Generation of virus particles, data analysis, patch-
clamping and imaging of organotypic hippocampal slices were accomplished 
by Stephan Direnberger at the MPI of Neurobiology. 
 
Figure 49A represents traces obtained from four independently measured 
cells stimulated with 1, 2, 5, 10 and 20 action potentials elicited at 20 Hz. As it 
can be seen calcium transients evoked by a single action potential are 
detected with TN-XXL that can be seen even in single experiments. According 
to the investigation at the Drosophila NMJ, signals seem to saturate when the 
number of action potentials was increased (Figure 49B).  
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Figure 49: In vitro responses of TN-XXL in organotypic hippocampal slices. 
(A) 20 Hz stimulation for 1, 2, 5, 10 and 20 action potentials (APs) for patched CA1 neurons. The APs 
are evoked by short triggered current pulses (0.2 - 0.4 nA for 10 ms/pulse). Each pulse elicits one action 
potential. The black bar below each trace displays the time of the electrical stimulation. The black lines 
show the ΔR/R in [%] of a single trial of each cell, the red line depicts the average of four individual cells. 
(B) Overview of the ΔR/Rmax dependence for 1, 2, 5, 10 and 20 AP at 20 Hz stimulation (n = 4, ±SEM). 
(C) A CA1 pyramidal neuron of a cultured hippocampal slice expressing TN-XXL. Scale bar, 5 μm. (D) 
Recordings of a single train for one patched CA1 neuron are plotted. Current injections evoke 1, 2, 5, 10 
and 20 action potentials. The upper graph displays the change of fluorescence intensity ΔF/F in [%] for 
the single channels (Citrine cp174 and CFP) during and after current injection. The graph combines all 
recordings from 1 to 20 AP. The lower graph shows the ratio ΔR/R in [%] calculated from the 
background subtracted single channels. (E) Electrophysiology data for a stimulation protocol of 1 AP 
and 10 AP at 20 Hz (black lines, with blow up) and the respective average ΔR/R in [%] (n = 4) (red 
lines). 
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Clear responses of TN-XXL were visible in single runs as it can be seen in 
Figure 49D that depicts the time course of the individual channels and the 
calculated ΔR/R value in [%] of a single measured cell (and therefore one trial 
per stimulus at 20 Hz). Average signals obtained from four different cells and 
example electrophysiology traces for one action potential and ten action 
potentials (at 20 Hz) are shown in Figure 49E with the enlarged images 
depicting  typical deflections in membrane potential that has been elicited by a 
single action potential or a burst of ten APs.  
Detection of a single action potential has not been achieved with one of the 
troponin C-based calcium indicators TN-L15 and TN-XL and sets a milestone 
in the development of GECIs and the usage of these indicators in in vivo 
experiments. 
It would be interesting to extend the stimulation paradigm and to investigate if 
synaptically evoked action potentials - by stimulation of a presynaptic cell and 
simultaneously recording of the indicator response in the postsynaptic cell - 
can also be detected by the use of TN-XXL. On the other hand it would be 
interesting to apply single action potentials at different interstimulus intervals 
to determine the minimum frequency at which these individual signals can be 
separated by the indicator. 
 
 
5.5. In vivo detection of sensory evoked calcium transient in 
mouse visual cortex 
 
Since TN-XXL displayed outstanding performance at the Drosophila NMJ and 
it was possible to sense single action potentials in organotypic hippocampal 
slices, this indicator should fulfill all the requirements needed for in vivo 
imaging of neuronal activity. 
In mice, sensory afferents project from the retina to the dLGN (dorsal laterate 
geniculate nucleus) before entering the V1 region of the primary visual cortex 
that consists of a major monocular and a minor (lateral) binocular region (84, 
85). Within the mouse primary visual cortex one can find orientation selective 
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neurons i.e. neurons that respond best to moving bars or gratings of a 
particular orientation or a subset of orientations in the receptive field (85). It 
was now, after the promising results reported above, of highest interest to see 
if this orientation tuning of neurons could be detected by means of calcium 
imaging performed on single cells using our GECI TN-XXL. 
For that reason expression of TN-XXL in the V1 region was achieved by 
infection with the semliki forest virus or by in utero electroporation. Cells in the 
monocular region were imaged using 2P-microscopy (with a 480/40 nm filter 
for CFP and a 535/30 nm filter for Citrine cp174) upon stimulation of the 
contralateral eye with moving bars of different orientations. Images were 
acquired at 1 Hz and the stimulus was applied for 5 s (separated by an inter 
stimulus interval of 5 s). 
 
I performed subcloning of TN-XXL into the pSCA vector that has been used to 
create virus particles. Generation of virus particles was carried out by Stephan 
Direnberger at the MPI of Neurobiology. In utero electroporation was 
accomplished by Christiaan Levelt at the Netherlands Institute for 
Neuroscience, Amsterdam (Netherlands). Infection of mouse visual cortex 
with the semliki forest virus, in vivo imaging and data analysis were performed 
by Alexandre Ferrao Santos at the MPI of Neurobiology. 
 
Figure 50 shows in vivo fluorescent responses of TN-XXL expressing neurons 
in V1. Detection of calcium signals was achieved no matter if the expression 
was driven by virus infection (Figure 50A and Figure 50B, two different cells 
each infected with the semliki forest virus) or by in utero electroporation 
(Figure 50C). As it can be extracted from the data depicted in Figure 50 one 
could indeed find cells that responded to a variety of different orientations 
which were detected using calcium imaging with genetically-encoded calcium 
indicators. To stress one major advantage of using GECIs the cell in Figure 
50C was repeatedly measured over several days. In contrast to the semiliki 
forest virus infection the in utero electroporation lead to a stable expression of 
the indicator in the neurons and therefore allows for chronic imaging. 
Expression obtained by virus delivery usually comes along with a change of 
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morphology of the cell and eventually cell death due to the overexpression 
that is promoted by the viral genomic promoter. 
 
 
Figure 50: In vivo detection of sensory evoked calcium transients using TN-XXL. 
(A) and (B) In vivo responses of two different cortical neurons in the V1 region (layer 2/3) of mice 
expressing TN-XXL after infection with the semliki forest virus. Grey bars indicate the time at which the 
given stimulation (depicted as arrows above) was applied. (C) Responses of a cortical neuron 
expressing TN-XXL after in utero electroporation. Chronic imaging was performed on that individual 
neuron for three successive sessions separated by one day. Data represent the average of six runs. 
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Calcium responses were recorded at three consecutive sessions separated by 
one day. In each session calcium transients could be detected with a stable 
major orientation for upward motion and with slightly varying signals for 
downward, downward-left and upper-rightward motion.  
These data represents - at least to our knowledge - the first example of 
functional and chronic in vivo calcium imaging using genetically-encoded 
calcium indicators reporting sensory evoked calcium transients in mice. 
 
 
5.6. Outlook 
 
All the data presented in this thesis clearly demonstrate the significant 
improvement obtained with the development of TN-XXL compared to the 
previous generation of troponin C-based calcium indicators. Detection of 
single action potentials in hippocampal slices and the detection of sensory 
evoked calcium transients in vivo are a basic prerequisite of functional calcium 
imaging that can now be performed with genetically-encoded calcium 
indicators. Although there is still room for improvement of TN-XXL e.g. in 
signal strength especially to small changes in the calcium level, our next step 
will be the generation of a transgenic mouse that expresses TN-XXL in 
neurons. Therefore I will use the Thy1.2 promoter that has been successfully 
applied to drive expression of various transgenes in the nervous system (61, 
86).  
Our group recently created transgenic mice that express a derivative of TN-
L15 using the Thy1.2 promoter. As already mentioned these transgenic mice 
showed a lack of sensitivity to single action potential evoked calcium 
transients. The goal is to close that gap by generating a transgenic mouse 
expressing the improved GECI TN-XXL that will allow for more sensitive and 
robust in vivo calcium imaging. This in turn would be a next step to realize the 
advantage of calcium imaging based on genetically-encoded calcium 
indicators - a ‘ready to image’ animal. 
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